Tableau INN - DCI
(version 2022)
Product (En) | Produit (Fr) | Class 2022 | HSC Report / CSH Rapport | Session | Year / Année |
List / Liste |
CAS No |
abacavir | abacavir | 2933.59 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 136470-78-5 |
abafungin | abafungine | 2941.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 129639-79-8 |
abagovomab | abagovomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 792921-10-9 |
abaloparatide | abaloparatide | 2937.19 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 247062-33-5 |
abametapir | abamétapir | 2933.39 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1762-34-1 |
abaperidone | abapéridone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 183849-43-6 |
abarelix | abarélix | 2937.19 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 78 | 183552-38-7 |
abatacept | abatacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 91 | 332348-12-6 |
abciximab | abciximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 143653-53-6 |
abdavomeran | abdavoméran | 3002.41 | NC2803Bc Ann. T/11 | HSC/67 | 2021 | 124 COVID-19 | 2417899-75-1 |
abecomotide | abécomotide | 3002.41 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 109 | 907596-50-3 |
abediterol | abéditérol | 2933.79 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 915133-65-2 |
abelacimab | abélacimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2098724-83-3 |
abemaciclib | abémaciclib | 2933.59 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1231929-97-7 |
abetimus | abétimus | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 81 | 167362-48-3 |
abexinostat | abexinostat | 2932.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 783355-60-2 |
abicipar pegol | abicipar pégol | 3907.29 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 108 | 1327278-94-3 |
abiraterone | abiratérone | 2937.29 | NC2116B1b Ann. R/7 | HSC/55 | 2015 | 74 | 154229-19-3 |
abitesartan | abitésartan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 137882-98-5 |
abituzumab | abituzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 109 | 1105038-73-0 |
abivertinib | abivertinib | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1557267-42-1 |
abrezekimab | abrézékimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2043952-59-4 |
abrilumab | abrilumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1342290-43-0 |
abrineurin | abrineurine | 2937.19 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 178535-93-8 |
abrocitinib | abrocitinib | 2935.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1622902-68-4 |
acalabrutinib | acalabrutinib | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1420477-60-6 |
acalisib | acalisib | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 870281-34-8 |
acapatamab | acapatamab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2314491-93-3 |
acarbose | acarbose | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 40 | 56180-94-0 |
acebilustat | acébilustat | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 943764-99-6 |
acemannan | acémannan | 3913.90 | 38.100 Ann. Q (No. 118) | HSC/11 | 1993 | 64 | 110042-95-0 |
acetorphine | acétorphine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 17 | 25333-77-1 |
acetylmethadol | acétylméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 509-74-0 |
aciclovir | aciclovir | 2933.59 | 38.100 Ann. Q (No. 119) | HSC/11 | 1993 | 42 | 59277-89-3 |
acipimox | acipimox | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 51037-30-0 |
acitazanolast | acitazanolast | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 114607-46-4 |
acitretin | acitrétine | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 56 | 55079-83-9 |
aclantate | aclantate | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 27 | 39633-62-0 |
aclerastide | aclérastide | 2933.29 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 227803-63-6 |
aclidinium bromide | bromure d'aclidinium | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 320345-99-1 |
aclimostat | aclimostat | 2934.99 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2082752-83-6 |
acolbifene | acolbifène | 2934.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 182167-02-8 |
acorafloxacin | acorafloxacine | 2933.49 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 111 | 878592-87-1 |
acoramidis | acoramidis | 2933.19 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 1446711-81-4 |
acotiamide | acotiamide | 2934.10 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 185106-16-5 |
acoziborole | acoziborole | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1266084-51-8 |
acreozast | acréozast | 2926.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 123548-56-1 |
acrisorcin | acrisorcine | 2933.99 | NC2116B1b Ann. R/6 | HSC/55 | 2015 | 13 | 7527-91-5 |
acrivastine | acrivastine | 2933.39 | 38.100 Ann. Q (No. 124) | HSC/11 | 1993 | 51 | 87848-99-5 |
acrizanib | acrizanib | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1229453-99-9 |
acrocinonide | acrocinonide | 2937.22 | 38.100 Ann. Q (No. 125) | HSC/11 | 1993 | 27 | 28971-58-6 |
acronine | acronine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 22 | 7008-42-6 |
actinium (225Ac) lintuzumab satetraxetan | actinium (225Ac) lintuzumab satétraxétan | 2844.42 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2209911-94-2 |
actoxumab | actoxumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1245634-25-6 |
acumapimod | acumapimod | 2933.19 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 836683-15-9 |
adafosbuvir | adafosbuvir | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1613589-09-5 |
adalimumab | adalimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 331731-18-1 |
adalimumab beta | adalimumab bêta | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1446410-95-2 |
adaprolol | adaprolol | 2922.19 | 40.260 Ann. L/2 (No. 38) | HSC/17 | 1996 | 63 | 101479-70-3 |
adargileukin alfa | adargileukine alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 89 | 250710-65-7 |
adarigiline | adarigiline | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1124197-79-0 |
adarotene | adarotène | 2918.29 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 496868-77-0 |
adatanserin | adatansérine | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 127266-56-2 |
adavivint | adavivint | 2933.39 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1467013-03-3 |
adavosertib | adavosertib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 955365-80-7 |
adebrelimab | adébrélimab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2247114-85-6 |
adecatumumab | adecatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 503605-66-1 |
adefovir | adéfovir | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 106941-25-7 |
adegramotide | adégramotide | 3002.41 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 115 | 1252802-98-4 |
adekalant | adékalant | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 227940-00-3 |
adelmidrol | adelmidrol | 2924.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 1675-66-7 |
aderbasib | aderbasib | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 791828-58-5 |
adibendan | adibendan | 2933.79 | 38.100 Ann. Q (No. 126) | HSC/11 | 1993 | 57 | 100510-33-6 |
adimlecleucel | adimlecleucel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 117 | |
adipiplon | adipiplon | 2933.59 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 840486-93-3 |
adlinacogene civaparvovec | adlinacogène civaparvovec | 3002.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2143579-02-4 |
adomeglivant | adoméglivant | 2924.29 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1488363-78-5 |
adomiparin sodium | adomiparine sodique | 3001.90 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 9041-08-1 |
adoprazine | adoprazine | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 222551-17-9 |
adrenomedullin pegol | adrénomedulline pégol | 2937.19 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1432735-93-7 |
adriforant | adriforant | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 943057-12-3 |
adrogolide | adrogolide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 171752-56-0 |
aducanumab | aducanumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1384260-65-4 |
afabicin | afabicine | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1518800-35-5 |
afacifenacin | afacifénacine | 2933.59 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 877606-63-8 |
afamelanotide | afamélanotide | 2937.19 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 75921-69-6 |
afamitresgene autoleucel | afamitresgène autoleucel | 3002.51 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | |
afasevikumab | afasévikumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1589503-30-9 |
afatinib | afatinib | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 850140-72-6 |
afegostat | afégostat | 2933.39 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 169105-89-9 |
afeletecan | afélétécan | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 85 | 215604-75-4 |
afelimomab | afélimomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 156227-98-4 |
afimoxifene | afimoxifène | 2922.19 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 68392-35-8 |
afizagabar | afizagabar | 2934.99 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1398496-82-6 |
aflibercept | aflibercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 862111-32-8 |
afovirsen | afovirsen | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 151356-08-0 |
afoxolaner | afoxolaner | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1093861-60-9 |
aftobetin | aftobétine | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1208971-05-4 |
afuresertib | afurésertib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1047644-62-1 |
afutuzumab | afutuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 949142-50-1 |
agalsidase alfa | agalsidase alfa | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 104138-64-9 |
agalsidase beta | agalsidase beta | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 104138-64-9 |
aganepag | aganépag | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 910562-18-4 |
aganirsen | aganirsen | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 1146887-67-3 |
agatolimod | agatolimod | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 207623-20-9 |
agerafenib | agérafénib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1188910-76-0 |
aglatimagene besadenovec | aglatimagène bésadénovec | 3002.90 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1621271-62-2 |
aglepristone | aglépristone | 2922.50 | 42.100 Ann. O (VII) | HSC/21 | 1998 | 70 | 124478-60-0 |
agomelatine | agomélatine | 2924.29 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 138112-76-2 |
alacizumab pegol | alacizumab pégol | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 934216-54-3 |
aladorian | aladorian | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 865433-00-7 |
alagebrium chloride | chlorure d'alagébrium | 2934.10 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 341028-37-3 |
alalevonadifloxacin | alalévonadifloxacine | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 706809-20-3 |
alamifovir | alamifovir | 2933.59 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 193681-12-8 |
alatrofloxacin | alatrofloxacine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 157182-32-6 |
albaconazole | albaconazole | 2933.59 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 187949-02-6 |
albenatide | albénatide | 3002.12 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1031700-39-6 |
albiglutide | albiglutide | 2937.19 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 782500-75-8 |
albinterferon alfa-2b | albinterféron alfa-2b | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 472960-22-8 |
albitiazolium bromide | bromure d'albitiazolium | 2934.10 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 321915-72-4 |
albusomatropin | albusomatropine | 2937.11 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1636119-82-8 |
albutrepenonacog alfa | albutrépénonacog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1357448-54-4 |
alcaftadine | alcaftadine | 2933.39 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 147084-10-4 |
alclofenac | alclofénac | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 23 | 22131-79-9 |
aldafermin | aldafermine | 2937.19 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1616639-03-2 |
aldesleukin | aldesleukin | 3504.00 | 38.100 Ann. Q (No. 128) | HSC/11 | 1993 | 63 | 110942-02-4 |
aldoxorubicin | aldoxorubicine | 2941.90 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1361644-26-9 |
aldumastat | aldumastat | 2933.59 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1957278-93-1 |
alectinib | alectinib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1256580-46-7 |
alefacept | aléfacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 84 | 222535-22-0 |
aleglitazar | aléglitazar | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 475479-34-6 |
alemcinal | alemcinal | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 150785-53-8 |
alemtuzumab | alemtuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 216503-57-0 |
aleplasinin | aléplasinine | 2933.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 481629-87-2 |
alfacalcidol | alfacalcidol | 2936.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 40 | 41294-56-8 |
alfatradiol | alfatradiol | 2907.29 | NC0730B2 Ann. M/4 | HSC/31 | 2003 | 84 | 57-91-0 |
alfentanil | alfentanil | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 43 | 71195-58-9 |
alferminogene tadenovec | alferminogène tadénovec | 3002.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 473553-86-5 |
alfimeprase | alfiméprase | 3507.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 259074-76-5 |
alglucosidase alfa | alglucosidase alfa | 3507.90 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 420784-05-0 |
alicaforsen | alicaforsen | 2934.99 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 185229-68-9 |
alicapistat | alicapistat | 2933.79 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1254698-46-8 |
alicdamotide | alicdamotide | 3002.41 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 109 | 1201327-17-4 |
alidornase alfa | alidornase alfa | 3507.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1788036-49-6 |
aligomanuxic acid | acide aligomanuxique | 3913.90 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 105280-81-7 |
aliloxibic acid | acide valiloxibique | 2922.49 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 238401-16-6 |
alilusem | alilusem | 2933.49 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 144506-11-6 |
alinastine | alinastine | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 154541-72-7 |
alipogene tiparvovec | alipogène tiparvovec | 3002.90 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 929881-05-0 |
alirinetide | alirinétide | 2925.29 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 725715-18-4 |
alirocumab | alirocumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1245916-14-6 |
alisertib | alisertib | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1028486-01-2 |
aliskiren | aliskirène | 2924.29 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 173334-57-1 |
alisporivir | alisporivir | 2933.79 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 254435-95-5 |
alitretinoin | alitrétinoïne | 2936.21 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 80 | 1241893 |
allobarbital | allobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 52-43-7 |
allopurinol | allopurinol | 2933.59 | 38.100 Ann. Q (No. 131) | HSC/11 | 1993 | 14 | 315-30-0 |
allylprodine | allylprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 25384-17-2 |
almagate | almagate | 2842.90 | 38.100 Ann. Q (No. 132) | HSC/11 | 1993 | 41 | 66827-12-1 |
almorexant | almorexant | 2933.49 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 871224-64-5 |
almotriptan | almotriptan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 154323-57-6 |
almurtide | almurtide | 2932.99 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 61136-12-7 |
alnespirone | alnespirone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 138298-79-0 |
alniditan | alniditan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 152317-89-0 |
alnuctamab | alnuctamab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2296827-07-9 |
alobresib | alobrésib | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1637771-14-2 |
alofanib | alofanib | 2935.90 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1612888-66-0 |
alogliptin | alogliptine | 2933.59 | NC1248B1b Ann. P/14 | HSC/40 | 2007 | 96 | 850649-61-5 |
aloxistatin | aloxistatine | 2924.29 | 38.100 Ann. Q (No. 133) | HSC/11 | 1993 | 57 | 88321-09-9 |
alpelisib | alpélisib | 2934.10 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1217486-61-7 |
alpertine | alpertine | 2933.59 | 38.100 Ann. Q (No. 134) | HSC/11 | 1993 | 34 | 27076-46-6 |
alphacetylmethadol | alphacétylméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-58-5 |
alphameprodine | alphaméprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 468-51-9 |
alphamethadol | alphaméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-54-1 |
alphaprodine | alphaprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 77-20-3 |
alprafenone | alprafénone | 2922.19 | 40.260 Ann. L/2 (No. 39) | HSC/17 | 1996 | 62 | 124316-02-5 |
alprazolam | alprazolam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 28981-97-7 |
alprenolol | alprénolol | 2922.19 | 40.260 Ann. L/2 (No. 40) | HSC/17 | 1996 | 19 | 13655-52-2 |
alsactide | alsactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 45 | 34765-96-3 |
alsevalimab | alsévalimab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2254029-91-7 |
altapizone | altapizone | 2933.59 | 38.100 Ann. Q (No. 135) | HSC/11 | 1993 | 55 | 93277-96-4 |
alteminostat | altéminostat | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1246374-97-9 |
altinicline | altinicline | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 179120-92-4 |
altiratinib | altiratinib | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1345847-93-9 |
altizide | altizide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 13 | 5588-16-9 |
altumomab | altumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 68 | 156586-92-4 |
alunacedase alfa | alunacédase alfa | 3507.90 | NC2803Bc Ann. T/11 | HSC/67 | 2021 | 124 COVID-19 | 2416824-55-8 |
alvameline | alvaméline | 2933.39 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 120241-31-8 |
alvelestat | alvélestat | 2933.79 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 848141-11-7 |
alvespimycin | alvespimycine | 2941.90 | NC1553B1b Ann. O/1 | HSC/45 | 2010 | 96 | 467214-20-6 |
alvimopan | alvimopan | 2933.39 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 156053-89-3 |
alvocidib | alvocidib | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 146426-40-6 |
amadinone | amadinone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 25 | 30781-27-2 |
amatuximab | amatuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 931402-35-6 |
ambasilide | ambasilide | 2933.39 | 38.100 Ann. Q (No. 137) | HSC/11 | 1993 | 59 | 83991-25-7 |
ambrisentan | ambrisentan | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 177036-94-1 |
ambruticin | ambruticine | 2941.90 | 38.100 Ann. Q (No. 138) | HSC/11 | 1993 | 39 | 58857-02-6 |
amcasertib | amcasertib | 2934.10 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1129403-56-0 |
amcenestrant | amcénestrant | 2933.99 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2114339-57-8 |
amcinafal | amcinafal | 2937.22 | 38.100 Ann. Q (No. 139) | HSC/11 | 1993 | 25 | 3924-70-7 |
amcinafide | amcinafide | 2937.22 | 38.100 Ann. Q (No. 140) | HSC/11 | 1993 | 25 | 7332-27-6 |
amcinonide | amcinonide | 2937.22 | 38.100 Ann. Q (No. 141) | HSC/11 | 1993 | 33 | 51022-69-6 |
amcipatricin | amcipatricine | 2941.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 143483-67-4 |
amdakefalin | amdakéfaline | 2933.59 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2253747-71-4 |
amdoxovir | amdoxovir | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 145514-04-1 |
amebucort | amébucort | 2937.29 | 38.100 Ann. Q (No. 142) | HSC/11 | 1993 | 54 | 83625-35-8 |
amediplase | amédiplase | 3507.90 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 151912-11-7 |
amelometasone | amélométasone | 2937.22 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 123013-22-9 |
amelparib | amelparib | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1227156-72-0 |
amelubant | amélubant | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 85 | 346735-24-8 |
amenamevir | aménamévir | 2934.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 841301-32-4 |
amfepramone | amfépramone | 2922.31 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 13 | 90-84-6 |
amfetamine | amfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 300-62-9 |
amfomycin | amfomycine | 2941.90 | 38.100 Ann. Q (No. 143) | HSC/11 | 1993 | 13 | 1402-82-0 |
amibegron | amibégron | 2922.50 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 121524-08-1 |
amifampridine | amifampridine | 2933.39 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 54-96-6 |
amiglumide | amiglumide | 2924.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 119363-62-1 |
amilintide | amilintide | 2937.19 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 76 | 122384-88-7 |
amilomotide | amilomotide | 3002.41 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 105 | 1238372-23-0 |
amiloxate | amiloxate | 2918.99 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 83 | 71617-10-2 |
aminoethyl nitrate | nitrate d'aminoéthyle | 2922.50 | 38.100 Ann. Q (No. 144) | HSC/11 | 1993 | 1 | 646-02-6 |
aminorex | aminorex | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 14 | 2207-50-3 |
amiselimod | amisélimod | 2922.50 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 942399-20-4 |
amitifadine | amitifadine | 2933.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 410074-73-6 |
amitriptylinoxide | amitriptylinoxyde | 2929.90 | 40.260 Ann. L/2 (No. 10) | HSC/17 | 1996 | 36 | 4317-14-0 |
amivantamab | amivantamab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2171511-58-1 |
amlintide | amlintide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 122384-88-7 |
amlivirsen | amlivirsen | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1637640-12-0 |
amobarbital | amobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 57-43-2 |
amolimogene bepiplasmid | amolimogène bépiplasmide | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 870524-46-2 |
amopyroquine | amopyroquine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 8 | 550-81-2 |
amotosalen | amotosalène | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 85 | 161262-29-9 |
amoxydramine camsilate | camsilate d'amoxydramine | 2929.90 | 40.260 Ann. L/2 (No. 11) | HSC/17 | 1996 | 15 | 15350-99-9 |
amphenidone | amphénidone | 2933.79 | 38.100 Ann. Q (No. 146) | HSC/11 | 1993 | 10 | 134-37-2 |
ampreloxetine | ampréloxétine | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1227056-84-9 |
amprenavir | amprénavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 79 | 161814-49-9 |
amsilarotene | amsilarotène | 2931.90 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 98 | 125973-56-0 |
amuvatinib | amuvatinib | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 850879-09-3 |
amylmetacresol | amylmétacrésol | 2907.19 | 38.100 Ann. Q (No. 147) | HSC/11 | 1993 | 55 | 1300-94-3 |
anacetrapib | anacétrapib | 2934.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 875446-37-0 |
anagestone | anagestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 2740-52-5 |
anagliptin | anagliptine | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 739366-20-2 |
anakinra | anakinra | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 143090-92-0 |
anamorelin | anamoréline | 2933.39 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 249921-19-5 |
anaritide | anaritide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 57 | 95896-08-5 |
anastrozole | anastrozole | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 120511-73-1 |
anatibant | anatibant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 88 | 209733-45-9 |
anatumomab mafenatox | anatumomab mafénatox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 79 | 0-00-0 |
anaxirone | anaxirone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 52 | 77658-97-0 |
anazocine | anazocine | 2933.39 | 38.100 Ann. Q (No. 151) | HSC/11 | 1993 | 30 | 15378-99-1 |
ancestim | ancestim | 3002.13 | NC2373B1b Ann. O/8 | HSC/59 | 2017 | 79 | 163545-26-4 |
ancremonam | ancrémonam | 2941.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1810051-96-7 |
ancriviroc | ancriviroc | 2933.39 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 370893-06-4 |
ancrod | ancrod | 3507.90 | 38.100 Ann. Q (No. 152) | HSC/11 | 1993 | 23 | 9046-56-4 |
andecaliximab | andécaliximab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1518996-49-0 |
andexanet alfa | andexanet alfa | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1262449-58-0 |
anecortave | anécortave | 2915.39 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 80 | 7753-60-8 |
anetumab corixetan | anétumab corixétan | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2222980-98-3 |
anetumab ravtansine | anétumab ravtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1375258-01-7 |
angiotensinamide | angiotensinamide | 2933.29 | 38.100 Ann. Q (No. 153) | HSC/11 | 1993 | 12 | 53-73-6 |
anidulafungin | anidulafungine | 2941.90 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 81 | 166663-25-8 |
anifrolumab | anifrolumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1326232-46-5 |
anileridine | aniléridine | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 144-14-9 |
anisperimus | anispérimus | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 170368-04-4 |
anistreplase | anistreplase | 3507.90 | 38.100 Ann. Q (No. 154) | HSC/11 | 1993 | 59 | 81669-57-0 |
anivamersen | anivamersen | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 959716-29-1 |
anrukinzumab | anrukinzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 910649-32-0 |
anseculin | anséculine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 155773-59-4 |
antazonite | antazonite | 2934.10 | 38.100 Ann. Q (No. 155) | HSC/11 | 1993 | 15 | 25422-75-7 |
antithrombin alfa | antithrombine alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 84720-88-7 |
antithrombin gamma | antithrombine gamma | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1311281-25-0 |
apabetalone | apabétalone | 2933.59 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1044870-39-4 |
apadamtase alfa | apadamtase alfa | 3507.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2086325-24-6 |
apadenoson | apadénoson | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 250386-15-3 |
apadoline | apadoline | 2934.30 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 135003-30-4 |
apaflurane | apaflurane | 2903.46 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 73 | 431-89-0 |
apalutamide | apalutamide | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 956104-40-8 |
apararenone | apararénone | 2935.90 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 945966-46-1 |
apatorsen | apatorsen | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1002331-21-6 |
apaxifylline | apaxifylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 151581-23-6 |
apaziquone | apaziquone | 2933.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 114560-48-4 |
apilimod | apilimod | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 541550-19-0 |
apimostinel | apimostinel | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1421866-48-9 |
apitegromab | apitégromab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2278276-46-1 |
apitolisib | apitolisib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1032754-93-0 |
apixaban | apixaban | 2933.79 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 503612-47-3 |
aplaviroc | aplaviroc | 2933.79 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 461443-59-4 |
aplindore | aplindore | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 92 | 189681-70-7 |
apolizumab | apolizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 87 | 267227-08-7 |
apraglutide | apraglutide | 2937.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1295353-98-8 |
apratastat | apratastat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 287405-51-0 |
apremilast | aprémilast | 2930.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 608141-41-9 |
aprepitant | aprépitant | 2934.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 170729-80-3 |
apricitabine | apricitabine | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 160707-69-7 |
apricoxib | apricoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 197904-84-0 |
aprinocarsen | aprinocarsen | 2934.99 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 151879-73-1 |
aprocitentan | aprocitentan | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1103522-45-7 |
aprutumab | aprutumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1634620-63-5 |
aprutumab ixadotin | aprutumab ixadotine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1708947-48-1 |
aptazapine | aptazapine | 2933.59 | 38.100 Ann. Q (No. 156) | HSC/11 | 1993 | 50 | 71576-40-4 |
aptiganel | aptiganel | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 137159-92-3 |
aramisulpride | aramisulpride | 2933.99 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 71675-90-6 |
arasertaconazole | arasertaconazole | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 583057-48-1 |
arazasetron | arazasétron | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2025360-90-9 |
arbaclofen | arbaclofène | 2922.49 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 69308-37-8 |
arbaclofen placarbil | arbaclofène placarbil | 2924.29 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 847353-30-4 |
arbekacin | arbékacine | 2941.90 | 38.100 Ann. Q (No. 157) | HSC/11 | 1993 | 56 | 51025-85-5 |
arcitumomab | arcitumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 154361-48-5 |
ardenermin | ardénermine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 88 | 305391-49-5 |
ardeparin sodium | ardéparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 68 | 9041-08-1 |
arfalasin | arfalasine | 2933.29 | 38.100 Ann. Q (No. 158) | HSC/11 | 1993 | 37 | 60173-73-1 |
arfolitixorin | arfolitixorine | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 316901-11-6 |
arformoterol | arformotérol | 2924.29 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 67346-49-0 |
arginine | arginine | 2925.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 14 | 74-79-3 |
argipressin | argipressine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 113-79-1 |
argiprestocin | argiprestocine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 13 | 113-80-4 |
arhalofenate | arhalofénate | 2924.29 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 24136-23-0 |
arimoclomol | arimoclomol | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 289893-25-0 |
aripiprazole | aripiprazole | 2933.79 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 129722-12-9 |
arlipoic acid | acide arlipoïque | 2934.99 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 1200-22-2 |
armodafinil | armodafinil | 2930.90 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 112111-43-0 |
arnolol | arnolol | 2922.19 | 38.100 Ann. Q (No. 160) | HSC/11 | 1993 | 56 | 87129-71-3 |
arofylline | arofylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 136145-07-8 |
arotinolol | arotinolol | 2934.10 | 38.100 Ann. Q (No. 161) | HSC/11 | 1993 | 48 | 68377-92-4 |
arpraziquantel | arpraziquantel | 2933.59 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 57452-98-9 |
arprinocid | arprinocide | 2933.59 | 38.100 Ann. Q (No. 162) | HSC/11 | 1993 | 38 | 55779-18-5 |
artefenomel | artéfénomel | 2934.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1029939-86-3 |
arteflene | artéflène | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 123407-36-3 |
artemisone | artémisone | 2934.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 255730-18-8 |
artemotil | artémotil | 2932.99 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 75887-54-6 |
artenimol | arténimol | 2932.99 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 81496-81-3 |
arterolane | artérolane | 2932.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 664338-39-0 |
arundic acid | acide arundique | 2915.90 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 185517-21-9 |
arzoxifene | arzoxifène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 182133-25-1 |
asalhydromorphone | asalhydromorphone | 2939.19 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1431529-94-0 |
asapiprant | asapiprant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 109 | 932372-01-5 |
asciminib | asciminib | 2933.39 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1492952-76-7 |
ascorbyl gamolenate | gamolénate d'ascorbyl | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 109791-32-4 |
ascrinvacumab | ascrinvacumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1463459-96-2 |
aselizumab | asélizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 88 | 395639-53-9 |
asenapine | asénapine | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 65576-45-6 |
aseripide | aséripide | 2934.10 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 153242-02-5 |
asfotase alfa | asfotase alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1174277-80-5 |
asimadoline | asimadoline | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 153205-46-0 |
asivatrep | asivatrep | 2935.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1005168-10-4 |
asobamast | asobamast | 2934.10 | 38.100 Ann. Q (No. 163) | HSC/11 | 1993 | 63 | 104777-03-9 |
asoprisnil | asoprisnil | 2937.29 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 86 | 199396-76-4 |
asoprisnil ecamate | ecamate d'asoprisnil | 2937.29 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 88 | 222732-94-7 |
aspacytarabine | aspacytarabine | 2934.99 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2098942-53-9 |
astegolimab | astégolimab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2173054-79-8 |
astemizole | astémizole | 2933.39 | 38.100 Ann. Q (No. 164) | HSC/11 | 1993 | 42 | 68844-77-9 |
astodrimer | astodrimère | 2924.29 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1379746-42-5 |
asudemotide | asudémotide | 3002.41 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 107 | 1018833-53-8 |
asunaprevir | asunaprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 630420-16-5 |
asundexian | asundexian | 2933.79 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2064121-65-7 |
asunercept | asunercept | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 114 | 1450882-18-4 |
asvasiran | asvasiran | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 870094-26-1 |
atabecestat | atabécestat | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1200493-78-2 |
atacicept | atacicept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 845264-92-8 |
ataciguat | ataciguat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 88 | 254877-67-3 |
atagabalin | atagabaline | 2922.49 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 223445-75-8 |
ataluren | ataluren | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 775304-57-9 |
atamestane | atamestane | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 96301-34-7 |
ataquimast | ataquimast | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 182316-31-0 |
atazanavir | atazanavir | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 198904-31-3 |
atecegatran | atécégatran | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 917904-13-3 |
atecegatran fexenetil | atécégatran fexénétil | 2933.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 433937-93-0 |
atelocantel | atélocantel | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1370540-16-1 |
atesidorsen | atésidorsen | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 872063-57-5 |
atexakin alfa | atexakine alfa | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 72 | 143631-61-2 |
atezolizumab | atézolizumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1380723-44-3 |
atibeprone | atibéprone | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 153420-96-3 |
atibuclimab | atibuclimab | 3002.13 | NC2803Bc Ann. T/11 | HSC/67 | 2021 | 124 COVID-19 | 2417175-94-9 |
aticaprant | aticaprant | 2933.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1174130-61-0 |
atidarsagene autotemcel | atidarsagène autotemcel | 3002.51 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | |
atidortoxumab | atidortoxumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1939108-95-8 |
atigliflozin | atigliflozine | 2940.00 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 647834-15-9 |
atilmotin | atilmotine | 2933.99 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 533927-56-9 |
atinumab | atinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 1226761-65-4 |
atiprimod | atiprimod | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 123018-47-3 |
atiprosin | atiprosine | 2933.59 | 38.100 Ann. Q (No. 166) | HSC/11 | 1993 | 54 | 89303-63-9 |
atiratecan | atiratécan | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 101 | 867063-97-6 |
atizoram | atizoram | 2933.59 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 135637-46-6 |
atleradstrocel | atléradstrocel | 3002.51 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | |
atliprofen | atliprofène | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 108912-17-0 |
atocalcitol | atocalcitol | 2909.49 | NC0938B2b Ann. O/1 | HSC/35 | 2005 | 88 | 302904-82-1 |
atogepant | atogépant | 2933.79 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1374248-81-3 |
atoltivimab | atoltivimab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2135632-29-8 |
atopaxar | atopaxar | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 751475-53-3 |
atorolimumab | atorolimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 80 | 202833-08-7 |
atorvastatin | atorvastatine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 134523-00-5 |
atrasentan | atrasentan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 195733-43-8 |
atreleuton | atréleuton | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 154355-76-7 |
atrimustine | atrimustine | 2922.49 | 40.260 Ann. L/2 (No. 42) | HSC/17 | 1996 | 61 | 75219-46-4 |
atromepine | atromépine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 15 | 428-07-9 |
atuveciclib | atuvéciclib | 2933.69 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1414943-94-4 |
audencel | audencel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 115 | |
auriclosene | auriclosène | 2929.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 846056-87-9 |
avacincaptad pegol | avacincaptad pégol | 3907.29 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 113 | 1613641-69-2 |
avacopan | avacopan | 2933.39 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1346623-17-3 |
avadomide | avadomide | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1015474-32-4 |
avagacestat | avagacestat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 104 | 1146699-66-2 |
avalglucosidase alfa | avalglucosidase alfa | 3507.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1802558-87-7 |
avalotcagene ontaparvovec | avalotcagène ontaparvovec | 3002.90 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2227000-30-6 |
avanafil | avanafil | 2933.59 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 330784-47-9 |
avanbulin | avanbuline | 2934.99 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 798577-91-0 |
avapritinib | avapritinib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1703793-34-3 |
avasimibe | avasimibe | 2929.90 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 80 | 166518-60-1 |
avasopasem manganese | avasopasem manganèse | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 120 | 435327-40-5 |
avatrombopag | avatrombopag | 2934.10 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 570406-98-3 |
avdoralimab | avdoralimab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2226393-85-5 |
avelumab | avélumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1537032-82-8 |
avexitide | avexitide | 2937.19 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 133514-43-9 |
avibactam | avibactam | 2933.39 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1192500-31-4 |
avipendekin pegol | avipendékine pégol | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2361317-09-9 |
aviptadil | aviptadil | 2933.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 40077-57-4 |
aviscumine | aviscumine | 3002.49 | NC2803Bc Ann. T/9 | HSC/67 | 2021 | 84 | 223577-45-5 |
avitriptan | avitriptan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 151140-96-4 |
avizakimab | avizakimab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2229685-51-0 |
avoplacel | avoplacel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 119 | |
avoralstat | avoralstat | 2933.39 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 918407-35-9 |
avorelin | avoréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 140703-49-7 |
avosentan | avosentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 93 | 290815-26-8 |
avotaciclib | avotaciclib | 2933.59 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1983983-41-0 |
avotermin | avotermine | 2934.99 | NC1649B3b Ann. R/10 | HSC/47 | 2011 | 77 | 182212-66-4 |
axalimogene filolisbac | axalimogén filolisbac | 3002.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | . |
axatilimab | axatilimab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2155851-88-8 |
axelopran | axélopran | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 949904-48-7 |
axicabtagene ciloleucel | axicabtagène ciloleucel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 117 | |
axitinib | axitinib | 2933.39 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 319460-85-0 |
axitirome | axitirome | 2924.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 156740-57-7 |
axomadol | axomadol | 2922.50 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 187219-95-0 |
azabon | azabon | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 16 | 1150-20-5 |
azalanstat | azalanstat | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 143393-27-5 |
azatadine | azatadine | 2933.39 | 38.100 Ann. Q (No. 170) | HSC/11 | 1993 | 18 | 3964-81-6 |
azathioprine | azathioprine | 2933.59 | 38.100 Ann. Q (No. 171) | HSC/11 | 1993 | 12 | 446-86-6 |
azelaprag | azélaprag | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2049980-18-7 |
azeliragon | azéliragon | 2933.29 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 603148-36-3 |
azeloprazole | azéloprazole | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 955095-45-1 |
azemiglitazone | azémiglitazone | 2934.10 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 1133819-87-0 |
azercabtagene zapreleucel | azercabtagène zapréleucel | 3002.51 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | |
azetirelin | azétiréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 95729-65-0 |
azilsartan | azilsartan | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 147403-03-0 |
azilsartan medoxomil | azilsartan médoxomil | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 863031-21-4 |
azimilide | azimilide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 149908-53-2 |
azintuxizumab | azintuxizumab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1826819-57-1 |
azintuxizumab vedotin | azintuxizumab védotine | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1826819-58-2 |
azoximer bromide | bromure d'azoximère | 3911.90 | NC1443B1b Ann. P/4 | HSC/43 | 2009 | 97 | 892497-01-7 |
bacmecillinam | bacmécillinam | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 38 | 50846-45-2 |
bafetinib | bafétinib | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 859212-16-1 |
balaglitazone | balaglitazone | 2934.10 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 199113-98-9 |
balamapimod | balamapimod | 2933.49 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 863029-99-6 |
balapiravir | balapiravir | 2934.99 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 690270-29-2 |
balazipone | balazipone | 2926.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 137109-71-8 |
balicatib | balicatib | 2933.59 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 354813-19-7 |
baliforsen | baliforsén | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1698048-23-5 |
balipodect | balipodect | 2933.19 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1238697-26-1 |
balixafortide | balixafortide | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1051366-32-5 |
balofloxacin | balofloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 127294-70-6 |
baloramotide | baloramotide | 3002.41 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2207581-19-7 |
balovaptan | balovaptan | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1228088-30-9 |
baloxavir marboxil | baloxavir marboxil | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1985606-14-1 |
balstilimab | balstilimab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2148321-77-9 |
baltaleucel | baltaleucel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 116 | |
balugrastim | balugrastim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 527698-09-5 |
bamadutide | bamadutide | 2937.19 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1596343-09-7 |
bamaquimast | bamaquimast | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 135779-82-7 |
baminercept | baminercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 909110-25-4 |
bamirastine | bamirastine | 2933.39 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 215529-47-8 |
bamlanivimab | bamlanivimab | 3002.13 | NC2803Bc Ann. T/11 | HSC/67 | 2021 | 124 COVID-19 | 2423943-37-5 |
bamocaftor | bamocaftor | 2935.90 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2204245-48-5 |
bamosiran | bamosiran | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1337968-84-9 |
banoxantrone | banoxantrone | 2929.90 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 136470-65-0 |
bapineuzumab | bapineuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 648895-38-9 |
bapotulimab | bapotulimab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2359413-58-2 |
barasertib | barasertib | 2933.59 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 722543-31-9 |
barbital | barbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 4 | 57-44-3 |
bardoxolone | bardoxolone | 2926.90 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 218600-44-3 |
barecetamab | barécétamab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2275727-74-5 |
baricitinib | baricitinib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 107 | 1187594-09-7 |
barixibat | barixibat | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 263562-28-3 |
barusiban | barusiban | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 285571-64-4 |
basifungin | basifungine | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 127785-64-2 |
basiliximab | basiliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 179045-86-4 |
basimglurant | basimglurant | 2933.39 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 802906-73-6 |
basmisanil | basmisanil | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1159600-41-5 |
batabulin | batabuline | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 90 | 195533-53-0 |
batefenterol | batéfentérol | 2933.79 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 743461-65-6 |
batimastat | batimastat | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 130370-60-4 |
batiraxcept | batiraxcept | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2268717-61-7 |
batoclimab | batoclimab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2187430-05-1 |
bavisant | bavisant | 2934.99 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 929622-08-2 |
bavituximab | bavituximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 648904-28-3 |
bazedoxifene | bazédoxifène | 2933.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 198481-32-2 |
bazlitoran | bazlitoran | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1378549-07-5 |
becampanel | bécampanel | 2933.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 188696-80-2 |
becaplermin | bécaplermine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 165101-51-9 |
becatecarin | becatecarine | 2941.90 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 119673-08-4 |
beclanorsen | béclanorsen | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 1072859-54-1 |
beclavubir | béclavubir | 2933.59 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 958002-33-0 |
becocalcidiol | bécocalcidiol | 2906.19 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 524067-21-8 |
bectumomab | bectumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 75 | 158318-63-9 |
bedaquiline | bédaquiline | 2933.49 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 843663-66-1 |
bederocin | bédérocine | 2934.99 | NC1553B1b Ann. O/4 | HSC/45 | 2010 | 99 | 757942-43-1 |
bedinvetmab | bédinvetmab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2171034-69-6 |
bedoradrine | bédoradrine | 2924.29 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 194785-19-8 |
befetupitant | béfétupitant | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 290296-68-3 |
befiradol | béfiradol | 2933.39 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 208110-64-9 |
befotertinib | béfotertinib | 2933.59 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1835667-63-4 |
befovacimab | béfovacimab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2156634-62-5 |
begacestat | bégacestat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 97 | 769169-27-9 |
begelomab | bégélomab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1403744-56-8 |
beinaglutide | béinaglutide | 2937.19 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 123475-27-4 |
belantamab | bélantamab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2061894-48-0 |
belantamab mafodotin | belantamab mafodotine | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2050232-20-5 |
belaperidone | bélapéridone | 2933.59 | 42.100 Ann. O (V) | HSC/21 | 1998 | 78 | 156862-51-0 |
belatacept | belatacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 706808-37-9 |
belinostat | bélinostat | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 97 | 414864-00-9 |
belizatinib | bélizatinib | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1357920-84-3 |
belnacasan | belnacasan | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 273404-37-8 |
beloranib | béloranib | 2922.19 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 251111-30-5 |
belotecan | bélotécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 91 | 256411-32-2 |
beloxepin | béloxépine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 135928-30-2 |
belumosudil | bélumosudil | 2933.59 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 911417-87-3 |
belvarafenib | belvarafénib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1446113-23-0 |
belzupacap sarotalocan | belzupacap sarotalocan | 3204.90 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2390462-37-8 |
belzutifan | belzutifan | 2930.90 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 1672668-24-4 |
bemarituzumab | bémarituzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1952272-74-0 |
bemcentinib | bemcentinib | 2933.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1037624-75-1 |
beminafil | béminafil | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 566906-50-1 |
bemiparin sodium | bémiparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 75 | 9041-08-1 |
bemotrizinol | bémotrizinol | 2933.69 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 187393-00-6 |
bempedoic acid | acide bempedoïque | 2918.19 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 738606-46-7 |
bempegaldesleukin | bempégaldesleukine | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1939126-74-5 |
benfurodil hemisuccinate | hémisuccinate de benfurodil | 2932.20 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 3447-95-8 |
benolizime | bénolizime | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 45 | 61864-30-0 |
benperidol | benpéridol | 2933.39 | 38.100 Ann. Q (No. 175) | HSC/11 | 1993 | 14 | 2062-84-2 |
benralizumab | benralizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1044511-01-4 |
bentamapimod | bentamapimod | 2934.20 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 848344-36-5 |
bentemazole | bentémazole | 2933.29 | 38.100 Ann. Q (No. 176) | HSC/11 | 1993 | 40 | 63927-95-7 |
bentracimab | bentracimab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2260568-31-6 |
benufutamab | bénufutamab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2109730-69-8 |
benzalkonium chloride | chlorure de benzalkonium | 3402.41 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 1 | 8001-54-5 |
benzethidine | benzéthidine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 9 | 3691-78-9 |
benzfetamine | benzfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 156-08-1 |
benzhydrocodone | benzhydrocodone | 2939.19 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1259440-61-3 |
benzindopyrine | benzindopyrine | 2933.39 | 38.100 Ann. Q (No. 177) | HSC/11 | 1993 | 13 | 16571-59-8 |
benzodrocortisone | benzodrocortisone | 2937.29 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 28956-89-0 |
benzonatate | benzonatate | 3402.42 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 6 | 104-31-4 |
benzopyrronium bromide | bromure de benzopyrronium | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 13696-15-6 |
benzpiperylone | benzpipérylone | 2933.39 | 38.100 Ann. Q (No. 55) | HSC/11 | 1993 | 13 | 53-89-4 |
beperminogene perplasmid | béperminogène perplasmide | 2934.99 | NC1310B1b Ann. N/7 | HSC/41 | 2008 | 95 | 627861-07-8 |
bepirovirsen | bépirovirsen | 2934.99 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1403787-62-1 |
bepotastine | bépotastine | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 125602-71-3 |
bepranemab | bépranémab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2244960-75-4 |
berdazimer sodium | berdazimère sodique | 3910.00 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1846565-00-1 |
beremagene geperpavec | bérémagène géperpavec | 3002.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2241888-62-8 |
berlafenone | berlafénone | 2922.19 | 40.260 Ann. L/2 (No. 43) | HSC/17 | 1996 | 63 | 18965-97-4 |
berlimatoxumab | berlimatoxumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1939109-24-6 |
bermekimab | bermékimab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1401965-15-8 |
beroctocog alfa | béroctocog alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 95 | 9001-27-8 |
berotralstat | bérotralstat | 2933.19 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1809010-50-1 |
bersacapavir | bersacapavir | 2935.90 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 1638266-40-6 |
bersanlimab | bersanlimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1987854-08-9 |
bertilimumab | bertilimumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 88 | 375348-49-5 |
berubicin | bérubicine | 2941.90 | NC1553B1b Ann. O/3 | HSC/45 | 2010 | 98 | 677017-23-1 |
berupipam | bérupipam | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 150490-85-0 |
bervastatin | bervastatine | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 132017-01-7 |
berzosertib | berzosertib | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1232416-25-9 |
besifloxacin | bésifloxacine | 2933.49 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 141388-76-3 |
besifovir | bésifovir | 2933.59 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 441785-25-7 |
besilesomab | besilesomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 537694-98-7 |
besipirdine | bésipirdine | 2933.39 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 119257-34-0 |
betacetylmethadol | bétacétylméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-59-6 |
betameprodine | bétaméprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 1 | 468-50-8 |
betamethadol | bétaméthadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 17199-55-2 |
betamicin | bétamicine | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 38 | 36889-15-3 |
betaprodine | bétaprodine | 2933.39 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 468-59-7 |
betasizofiran | bétasizofiran | 3913.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 39464-87-4 |
betaxolol | bétaxolol | 2922.19 | 40.260 Ann. L/2 (No. 44) | HSC/17 | 1996 | 40 | 63659-18-7 |
betiatide | bétiatide | 2930.90 | 38.100 Ann. Q (No. 179) | HSC/11 | 1993 | 58 | 103725-47-9 |
betibeglogene autotemcel | bétibéglogène autotemcel | 3002.51 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | |
betibeglogene darolentivec | bétibéglogène darolentivec | 3002.90 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1905394-85-5 |
betoxycaine | bétoxycaïne | 2922.50 | 40.260 Ann. L/2 (No. 9) | HSC/17 | 1996 | 13 | 3818-62-0 |
betrixaban | bétrixaban | 2933.39 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 330942-05-7 |
bevacizumab | bevacizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 216974-75-3 |
bevacizumab beta | bévacizumab bêta | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1438851-35-4 |
bevasiranib | bévasiranib | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 959961-96-7 |
bevenopran | bévénopran | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 676500-67-7 |
bevifimod | bévifimod | 2933.29 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2223113-32-2 |
bevirimat | bévirimat | 2918.19 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 174022-42-5 |
bexaglifozin | bexaglifozine | 2932.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1118567-05-7 |
bexarotene | bexarotène | 2916.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 153559-49-0 |
bexlosteride | bexlostéride | 2933.79 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 148905-78-6 |
bexmarilimab | bexmarilimab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2259301-27-2 |
bezafibrate | bézafibrate | 2924.29 | 38.100 Ann. Q (No. 180) | HSC/11 | 1993 | 35 | 41859-67-0 |
bezitramide | bézitramide | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 15 | 15301-48-1 |
bezlotoxumab | bezlotoxumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1246264-45-8 |
biapenem | biapénem | 2941.90 | 39.600 Ann. D/1, par. 15 | HSC/16 | 1995 | 69 | 120410-24-4 |
bibapcitide | bibapcitide | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 153507-46-1 |
bicalutamide | bicalutamide | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 90357-06-5 |
bictegravir | bictégravir | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1611493-60-7 |
bifarcept | bifarcept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 86 | 163796-60-9 |
bifeprunox | biféprunox | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 350992-10-8 |
bifikafusp alfa | bifikafusp alfa | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1957239-90-5 |
bilastine | bilastine | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 202189-78-4 |
bimagrumab | bimagrumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1356922-05-8 |
bimatoprost | bimatoprost | 2937.50 | NC0730B2 Ann. M/4 (III) | HSC/31 | 2003 | 85 | 155206-00-1 |
bimekizumab | bimékizumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1418205-77-2 |
bimiralisib | bimiralisib | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1225037-39-7 |
bimoclomol | bimoclomol | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 130493-03-7 |
bimosiamose | bimosiamose | 2940.00 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 187269-40-5 |
binetrakin | binétrakine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 207137-56-2 |
binfloxacin | binfloxacine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 108437-28-1 |
binimetinib | binimétinib | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 606143-89-9 |
binizolast | binizolast | 2933.59 | 38.100 Ann. Q (No. 182) | HSC/11 | 1993 | 60 | 86662-54-6 |
binodenoson | binodénoson | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 144348-08-3 |
bintrafusp alfa | bintrafusp alfa | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1918149-01-5 |
birabresib | birabrésib | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 202590-98-5 |
biricodar | biricodar | 2933.39 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 159997-94-1 |
birinapant | birinapant | 2933.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1260251-31-7 |
biriperone | biripérone | 2933.59 | 40.260 Ann. L/2 (No. 21) | HSC/17 | 1996 | 51 | 41510-23-0 |
birtamimab | birtamimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1608108-91-3 |
bisaramil | bisaramil | 2933.39 | 38.100 Ann. Q (No. 183) | HSC/11 | 1993 | 60 | 89194-77-4 |
bisegliptin | biségliptine | 2933.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 862501-61-9 |
bisnafide | bisnafide | 2925.19 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 144849-63-8 |
bisoctrizole | bisoctrizole | 2933.99 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 103597-45-1 |
bisoprolol | bisoprolol | 2922.19 | 40.260 Ann. L/2 (No. 45) | HSC/17 | 1996 | 48 | 66722-44-9 |
bivalirudin | bivalirudine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 128270-60-0 |
bivatuzumab | bivatuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 83 | 214559-60-1 |
bixalomer | bixalomère | 3911.90 | NC1760B1b Ann. N/3 | HSC/49 | 2012 | 101 | 851373-13-2 |
bizalimogene ralaplasmid | bizalimogène ralaplasmide | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1977488-08-6 |
blarcamesine | blarcamésine | 2932.19 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 195615-83-9 |
bleselumab | blésélumab | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1453067-91-8 |
blinatumomab | blinatumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 853426-35-4 |
blisibimod | blisibimod | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1236126-45-6 |
blonanserin | blonansérine | 2933.59 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 132810-10-7 |
blontuvetmab | blontuvetmab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1608112-78-2 |
blosozumab | blosozumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1132758-87-2 |
boceprevir | bocéprévir | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 394730-60-0 |
bococizumab | bococizumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1407495-02-6 |
bomedemstat | bomédemstat | 2933.59 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 1990504-34-1 |
bornaprolol | bornaprolol | 2922.19 | 40.260 Ann. L/2 (No. 46) | HSC/17 | 1996 | 46 | 66451-06-7 |
borofalan (10B) | borofalan (10B) | 2845.20 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 118 | 80994-59-8 |
bortezomib | bortezomib | 2933.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 179324-69-7 |
bosentan | bosentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 70 | 147536-97-8 |
bosutinib | bosutinib | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 380843-75-4 |
bovhyaluronidase azoximer | bovhyaluronidase azoximère | 3507.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1383710-57-3 |
bradanicline | bradanicline | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 639489-84-2 |
branaplam | branaplam | 2933.39 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1562338-42-4 |
branebrutinib | branébrutinib | 2933.39 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 1912445-55-6 |
brasofensine | brasofensine | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 171655-91-7 |
brazergoline | brazergoline | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 37 | 60019-20-7 |
brazikumab | brazikumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1610353-18-8 |
brecanavir | brécanavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 313682-08-5 |
bremazocine | brémazocine | 2933.39 | 38.100 Ann. Q (No. 185) | HSC/11 | 1993 | 43 | 71990-00-6 |
bremelanotide | brémélanotide | 2933.79 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 189691-06-3 |
brensocatib | brensocatib | 2934.99 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 1802148-05-5 |
brentuximab vedotin | brentuximab védotine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 914088-09-08 |
brepocitinib | brépocitinib | 2933.59 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 1883299-62-4 |
brexanolone | brexanolone | 2914.40 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 516-54-1 |
brexpiprazole | brexpiprazole | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 913611-97-9 |
briakinumab | briakinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 339308-60-0 |
briciclib | briciclib | 2930.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 865783-99-9 |
brifentanil | brifentanil | 2933.34 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 63 | 101345-71-5 |
brigatinib | brigatinib | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1197953-54-0 |
brilacidin | brilacidine | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1224095-98-0 |
brilanestrant | brilanestrant | 2933.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1365888-06-7 |
brilaroxazine | brilaroxazine | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1239729-06-6 |
brimapitide | brimapitide | 2933.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1445179-97-4 |
brincidofovir | brincidofovir | 2933.59 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 444805-28-1 |
brinzolamide | brinzolamide | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 76 | 138890-62-7 |
briobacept | briobacept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 869881-54-9 |
brivanib alaninate | brivanib alaninate | 2933.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 649735-63-7 |
brivaracetam | brivaracetam | 2933.79 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 357336-20-0 |
brivoligide | brivoligide | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1803075-42-4 |
brobactam | brobactam | 2941.90 | 42.100 Ann. O (II) | HSC/21 | 1998 | 53 | 26631-90-3 |
brodalumab | brodalumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1174395-19-7 |
brolamfetamine | brolamfétamine | 2922.29 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 64638-07-9 |
brolucizumab | brolucizumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1531589-13-5 |
bromazepam | bromazépam | 2933.33 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 22 | 1812-30-2 |
bromerguride | bromerguride | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 51 | 83455-48-5 |
brometenamine | brométénamine | 2933.69 | 40.260 Ann. L/2 (No. 22) | HSC/17 | 1996 | 12 | 15585-71-4 |
bromhexine | bromhexine | 2921.59 | 38.100 Ann. Q (No. 188) | HSC/11 | 1993 | 20 | 3572-43-8 |
bromindione | bromindione | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 12 | 1146-98-1 |
brontictuzumab | brontictuzumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1447814-75-6 |
broperamole | bropéramole | 2933.39 | 38.100 Ann. Q (No. 190) | HSC/11 | 1993 | 42 | 33144-79-5 |
brostallicin | brostallicine | 2933.99 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 203258-60-0 |
brotizolam | brotizolam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 40 | 57801-81-7 |
bucelipase alfa | bucélipase alfa | 3507.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 9026-00-0 |
buciclovir | buciclovir | 2933.59 | 38.100 Ann. Q (No. 191) | HSC/11 | 1993 | 52 | 86304-28-1 |
budesonide | budésonide | 2937.29 | 38.100 Ann. Q (No. 192) | HSC/11 | 1993 | 37 | 51333-22-3 |
budigalimab | budigalimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2098225-93-3 |
budiodarone | budiodarone | 2932.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 335148-45-3 |
budotitane | budotitane | 2914.40 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 56 | 85969-07-9 |
bulaquine | bulaquine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 223661-25-4 |
bulevirtide | bulévirtide | 2933.29 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2012558-47-1 |
bumepidil | bumépidil | 2933.59 | 38.100 Ann. Q (No. 194) | HSC/11 | 1993 | 44 | 62052-97-5 |
bunaprolast | bunaprolast | 2915.39 | 38.100 Ann. Q (No. 195) | HSC/11 | 1993 | 60 | 99107-52-5 |
bunazosin | bunazosine | 2933.59 | 38.100 Ann. Q (No. 196) | HSC/11 | 1993 | 50 | 80755-51-7 |
bunolol | bunolol | 2922.19 | 40.260 Ann. L/2 (No. 47) | HSC/17 | 1996 | 22 | 27591-01-1 |
buparlisib | buparlisib | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 944396-07-0 |
bupranolol | bupranolol | 2922.19 | 40.260 Ann. L/2 (No. 48) | HSC/17 | 1996 | 27 | 14556-46-8 |
buprenorphine | buprénorphine | 2939.11 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 29 | 52485-79-7 |
buquiterine | buquitérine | 2933.59 | 38.100 Ann. Q (No. 197) | HSC/11 | 1993 | 53 | 76536-74-8 |
burapitant | burapitant | 2934.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 537034-22-3 |
burixafor | burixafor | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1191448-17-5 |
burlulipase | burlulipase | 3507.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1261982-91-5 |
burosumab | burosumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1610833-03-8 |
buserelin | buséréline | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 36 | 57982-77-1 |
busulfan | busulfan | 2905.39 | 42.100 Ann. O (I) | HSC/21 | 1998 | 6 | 55-98-1 |
butalbital | butalbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 4 | 77-26-9 |
butamirate | butamirate | 2922.19 | 40.260 Ann. L/2 (No. 49) | HSC/17 | 1996 | 22 | 18109-80-3 |
buthalital sodium | buthalital sodique | 2933.59 | 38.100 Ann. Q (No. 199) | HSC/11 | 1993 | 8 | 510-90-7 |
butixocort | butixocort | 2937.29 | 38.100 Ann. Q (No. 200) | HSC/11 | 1993 | 63 | 120815-74-9 |
butofilolol | butofilolol | 2922.19 | 40.260 Ann. L/2 (No. 50) | HSC/17 | 1996 | 40 | 64552-17-6 |
butorphanol | butorphanol | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 42408-82-2 |
butropium bromide | bromure de butropium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 30 | 29025-14-7 |
butylphthalide | butylphthalide | 2932.20 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 6066-49-5 |
cabazitaxel | cabazitaxel | 2932.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 183133-96-2 |
cabiotraxetan | cabiotraxétan | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 451478-45-8 |
cabiralizumab | cabiralizumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1613144-80-1 |
cabotegravir | cabotégravir | 2934.99 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1051375-10-0 |
cabozantinib | cabozantinib | 2933.49 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 849217-68-1 |
cadalimogene ixalentivec | cadalimogène ixalentivec | 3002.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2137091-21-3 |
cadazolid | cadazolid | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1025097-10-2 |
cadrofloxacin | cadrofloxacine | 2933.59 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 153808-85-6 |
cagrilintide | cagrilintide | 2937.19 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1415456-99-3 |
calaspargase pegol | calaspargase pégol | 3507.90 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 941577-06-6 |
calcium carbimide | carbimide calcique | 3102.90 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 10 | 156-62-7 |
calcobutrol | calcobutrol | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 79 | 151878-23-8 |
caldaret | caldaret | 2933.59 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 133804-44-1 |
caloxetic acid | acide caloxétique | 2922.50 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 135306-78-4 |
camazepam | camazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 36104-80-0 |
camicinal | camicinal | 2933.59 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 923565-21-3 |
camidanlumab | camidanlumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 921618-45-3 |
camidanlumab tesirine | camidanlumab tésirine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1853239-04-9 |
camobucol | camobucol | 2930.90 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 216167-92-9 |
camrelizumab | camrélizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1798286-48-2 |
camsirubicin | camsirubicine | 2941.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 236095-26-4 |
canagliflozin | canagliflozine | 2934.99 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 842133-18-0 |
canakinumab | canakinumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 97 | 402710-27-4 (light chain) 402710-25-2 (heavy chain) |
candesartan | candésartan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 139481-59-7 |
candocuronium iodide | iodure de candocuronium | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 54278-85-2 |
canerpaturev | canerpaturev | 3002.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1662666-66-1 |
canertinib | canertinib | 2934.99 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 267243-28-7 |
canfosfamide | canfosfamide | 2930.90 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 158382-37-7 |
cangrelor | cangrélor | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 163706-06-7 |
cannabidiol | cannabidiol | 2907.29 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 13956-29-1 |
canoctakin | canoctakine | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1019859-03-0 |
canosimibe | canosimibe | 2933.79 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 768394-99-6 |
cantharidin | cantharidine | 2932.19 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 56-25-7 |
cantuzumab ravtansine | cantuzumab ravtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 868747-45-9 |
capadenoson | capadénoson | 2934.10 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 544417-40-5 |
capecitabine | capécitabine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 72 | 154361-50-9 |
capeserod | capésérod | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 769901-96-4 |
capivasertib | capivasertib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1143532-39-1 |
caplacizumab | caplacizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 106 | 915810-67-2 |
capmatinib | capmatinib | 2933.49 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1029712-80-8 |
capravirine | capravirine | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 178979-85-6 |
capromab | capromab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 151763-64-3 |
capromorelin | capromoréline | 2933.99 | NC1874B1b Ann. O/3 | HSC/51 | 2013 | 83 | 193273-66-4 |
capsaicin | capsaïcine | 2939.79 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 404-86-4 |
carabersat | carabersat | 2932.99 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 184653-84-7 |
carafiban | carafiban | 2933.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 177563-40-5 |
carbaldrate | carbaldrate | 2842.90 | 40.260 Ann. L/2 (No. 4) | HSC/17 | 1996 | 53 | 41342-54-5 |
carbasalate calcium | carbasalate calcique | 2924.29 | 38.100 Ann. Q (No. 202) | HSC/11 | 1993 | 27 | 5749-67-7 |
carbazocine | carbazocine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 16 | 15686-38-1 |
carbetimer | carbétimère | 3911.90 | 38.100 Ann. Q (No. 204) | HSC/11 | 1993 | 50 | 82230-03-3 |
carboplatin | carboplatine | 2843.90 | 38.100 Ann. Q (No. 205) | HSC/11 | 1993 | 48 | 41575-94-4 |
carfenazine | carfénazine | 2934.30 | 38.100 Ann. Q (No. 206) | HSC/11 | 1993 | 12 | 2622-30-2 |
carfilzomib | carfilzomib | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 868540-17-4 |
carfloglitazar | carfloglitazar | 2933.99 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2213406-75-6 |
carglumic acid | acide carglumique | 2924.19 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 84 | 1188-38-1 |
caricotamide | caricotamide | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 64881-21-6 |
cariporide | cariporide | 2930.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 159138-80-4 |
cariprazine | cariprazine | 2933.59 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 839712-12-8 |
carisbamate | carisbamate | 2924.29 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 194085-75-1 |
carlumab | carlumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 104 | 915404-94-3 |
carmegliptin | carmégliptine | 2933.79 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 813452-18-5 |
carmofur | carmofur | 2933.59 | 38.100 Ann. Q (No. 207) | HSC/11 | 1993 | 45 | 61422-45-5 |
carmoterol | carmotérol | 2933.79 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 147568-66-9 |
carotegrast | carotégrast | 2933.59 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 401904-75-4 |
carotuximab | carotuximab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1268714-50-6 |
cartasteine | cartastéine | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 149079-51-6 |
carumonam | carumonam | 2941.90 | 38.100 Ann. Q (No. 208) | HSC/11 | 1993 | 51 | 87638-04-8 |
casimersen | casimersen | 2934.99 | NC2447B1b Ann. N/2 | HSC/60 | 2017 | 115 | 1422958-19-7 |
casirivimab | casirivimab | 3002.13 | NC2803Bc Ann. T/11 | HSC/67 | 2021 | 124 COVID-19 | 2415933-42-3 |
casopitant | casopitant | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 414910-27-3 |
caspofungin | caspofungine | 2941.90 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 162808-62-0 |
catequentinib | catéquentinib | 2933.49 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 1058156-90-3 |
cathine | cathine | 2939.43 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 44 | 492-39-7 |
cathinone | cathinone | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 44 | 71031-15-7 |
catramilast | catramilast | 2933.29 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 183659-72-5 |
catridecacog | catridécacog | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 606138-08-3 |
catumaxomab | catumaxomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 93 | 509077-98-9 |
cavosonstat | cavosonstat | 2933.49 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1371587-51-7 |
cebranopadol | cébranopadol | 2934.99 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 863513-91-1 |
ceclazepide | céclazépide | 2933.39 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1801749-44-9 |
cedazuridine | cédazuridine | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1141397-80-9 |
cedelizumab | cédélizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 156586-90-2 |
cediranib | cédiranib | 2933.59 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 288383-20-0 |
cedirogant | cédirogant | 2933.39 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2055496-11-0 |
cefiderocol | céfidérocol | 2941.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1225208-94-5 |
cefilavancin | céfilavancine | 2941.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 722454-12-8 |
cefluprenam | céfluprénam | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 116853-25-9 |
cefmatilen | cefmatilène | 2941.90 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 140128-74-1 |
cefoselis | céfosélis | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 71 | 122841-10-5 |
cefovecin | céfovécine | 2941.90 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 234096-34-5 |
cefquinome | cefquinome | 2941.90 | 38.100 Ann. Q (No. 209) | HSC/11 | 1993 | 59 | 84957-30-2 |
ceftaroline fosamil | ceftaroline fosamil | 2941.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 229016-73-3 |
cefteram | ceftéram | 2941.90 | 38.100 Ann. Q (No. 210) | HSC/11 | 1993 | 55 | 82547-58-8 |
ceftizoxime alapivoxil | ceftizoxime alapivoxil | 2941.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 135821-54-4 |
ceftobiprole | ceftobiprole | 2941.90 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 209467-52-7 |
ceftobiprole medocaril | ceftobiprole médocaril | 2941.90 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 376653-43-9 |
ceftolozane | ceftolozane | 2941.90 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 689293-68-3 |
cefuzonam | céfuzonam | 2941.90 | 38.100 Ann. Q (No. 211) | HSC/11 | 1993 | 55 | 82219-78-1 |
celecoxib | célécoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 169590-42-5 |
celgosivir | celgosivir | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 77 | 121104-96-9 |
celivarone | célivarone | 2932.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 401925-43-7 |
cemadotin | cémadotine | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 159776-69-9 |
cemdisiran | cemdisiran | 2934.99 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1639264-46-2 |
cemiplimab | cémiplimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1801342-60-8 |
cendakimab | cendakimab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2151032-62-9 |
cenderitide | cendéritide | 2937.19 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 507289-11-4 |
cenegermin | cénégermine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1772578-74-1 |
cenerimod | cénérimod | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1262414-04-9 |
cenersen | cénersen | 2934.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 872847-66-0 |
cenicriviroc | cénicriviroc | 2933.29 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 497223-25-3 |
cenisertib | cénisertib | 2933.59 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 871357-89-0 |
cenobamate | cénobamate | 2933.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 913088-80-9 |
cenplacel | cenplacel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 115 | |
censavudine | censavudine | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 634907-30-5 |
centanafadine | centanafadine | 2933.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 924012-43-1 |
centhaquine | centhaquine | 2933.59 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 57961-90-7 |
cenupatide | cénupatide | 2925.29 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1006388-38-0 |
cepeginterferon alfa-2b | cépeginterféron alfa-2b | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1192706-52-7 |
ceralasertib | céralasertib | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1352226-88-0 |
ceralifimod | céralifimod | 2933.99 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 891859-12-4 |
cerdulatinib | cerdulatinib | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1198300-79-6 |
cergutuzumab amunaleukin | cergutuzumab amunaleukine | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1509916-03-3 |
ceritinib | céritinib | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1032900-25-6 |
cerivastatin | cérivastatine | 2933.39 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 145599-86-6 |
cerlapirdine | cerlapirdine | 2933.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 925448-93-7 |
cerliponase alfa | cerliponase alfa | 3507.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 151662-36-1 |
certolizumab pegol | certolizumab pegol | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 90 | 428863-50-7 |
certoparin sodium | certoparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 70 | 0-00-0 |
ceruletide | cérulétide | 2933.79 | 40.260 Ann. L/2 (No. 23) | HSC/17 | 1996 | 34 | 17650-98-5 |
cetermin | cétermine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 74 | 157238-32-9 |
cethromycin | céthromycine | 2941.90 | NC0845B2 Ann. M/1 (II) | HSC/33 | 2004 | 87 | 205110-48-1 |
cetilistat | cétilistat | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 282526-98-1 |
cetrelimab | cétrélimab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2050478-92-5 |
cetrimide | cétrimide | 3808.94 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 46 | 505-86-2 |
cetuximab | cétuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 82 | 205923-56-4 |
cetuximab sarotalocan | cétuximab sarotalocan | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2166339-33-7 |
cevaretigene ritoparvovec | cévarétigène ritoparvovec | 3002.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2247971-00-0 |
cevidoplenib | cévidoplénib | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1703788-21-9 |
cevimeline | céviméline | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 107233-08-9 |
cevipabulin | cévipabulin | 2933.59 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 849550-05-6 |
cevoglitazar | cévoglitazar | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 94 | 839673-52-8 |
cevostamab | cévostamab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2249888-53-5 |
chloralodol | chloralodol | 2911.00 | 42.100 Ann. O (I) | HSC/21 | 1998 | 12 | 3563-58-4 |
chlordiazepoxide | chlordiazépoxide | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 11 | 58-25-3 |
chlorotrianisene | chlorotrianisène | 2909.30 | 38.100 Ann. Q (No. 212) | HSC/11 | 1993 | 6 | 569-57-3 |
choline fenofibrate | fénofibrate de choline | 2923.10 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 856676-23-8 |
choriogonadotropin alfa | choriogonadotropine alfa | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 177073-44-8 |
choriogonadotropin beta | choriogonadotropine bêta | 2937.19 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2170458-11-2 |
ciaftalan zinc | ciaftalane zinc | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 14320-04-8 |
cibinetide | cibinétide | 2933.79 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1208243-50-8 |
cibisatamab | cibisatamab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1855925-27-7 |
ciclesonide | ciclésonide | 2937.29 | 38.100 Ann. Q (No. 213) | HSC/11 | 1993 | 74 | 141845-82-1 |
cicloprolol | cicloprolol | 2922.19 | 40.260 Ann. L/2 (No. 51) | HSC/17 | 1996 | 48 | 63659-12-1 |
ciclosporin | ciclosporine | 3002.13 | NC2570B1b Ann. M/19 | HSC/62 | 2018 | 46 | 59865-13-3 |
cidofovir | cidofovir | 2933.59 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 113852-37-2 |
ciforadenant | ciforadénant | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1202402-40-1 |
cilengitide | cilengitide | 2933.79 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 188968-51-6 |
cilgavimab | cilgavimab | 3002.13 | NC2803Bc Ann. T/11 | HSC/67 | 2021 | 124 COVID-19 | 2420563-99-9 |
cilmostim | cilmostim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 71 | 148637-05-2 |
cilobradine | cilobradine | 2933.79 | 38.100 Ann. Q (No. 214) | HSC/11 | 1993 | 66 | 109859-78-1 |
cilofexor | cilofexor | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1418274-28-8 |
cilofungin | cilofungine | 2941.90 | 38.100 Ann. Q (No. 215) | HSC/11 | 1993 | 60 | 79404-91-4 |
cilomilast | cilomilast | 2926.90 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 153259-65-5 |
ciltacabtagene autoleucel | ciltacabtagène autoleucel | 3002.51 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | |
ciluprevir | ciluprévir | 2934.10 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 300832-84-2 |
cimaglermin alfa | cimaglermine alfa | 2934.99 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1350717-96-2 |
cimlanod | cimlanod | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1620330-72-4 |
cinacalcet | cinacalcet | 2921.49 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 226256-56-0 |
cinaciguat | cinaciguat | 2922.50 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 329773-35-5 |
cinalukast | cinalukast | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 128312-51-6 |
cinamolol | cinamolol | 2922.19 | 40.260 Ann. L/2 (No. 52) | HSC/17 | 1996 | 44 | 39099-98-4 |
cindunistat | cindunistat | 2930.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 364067-22-1 |
cinhyaluronate sodium | cinhyaluronate de sodium | 3913.90 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1372784-20-7 |
cinpanemab | cinpanémab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2094516-02-4 |
cinrebafusp alfa | cinrébafusp alfa | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2218515-90-1 |
cintirorgon | cintirorgon | 2935.90 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1227156-72-0 |
cintredekin besudotox | cintrédékine bésudotox | 3002.49 | NC2803Bc Ann. T/9 | HSC/67 | 2021 | 92 | 372075-36-0 |
cipaglucosidase alfa | cipaglucosidase alfa | 3507.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2359727-71-0 |
cipamfylline | cipamfylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 132210-43-6 |
cipargamin | cipargamine | 2933.79 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 1193314-23-6 |
cipemastat | cipémastat | 2933.39 | NC0250B2 Ann. P/1 (II) | HSC/25 | 2000 | 81 | 190648-49-8 |
cipralisant | cipralisant | 2933.29 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 213027-19-1 |
ciraparantag | ciraparantag | 2933.59 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1438492-26-2 |
cirtuvivint | cirtuvivint | 2933.59 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2143917-62-6 |
cisatracurium besilate | bésilate de cisatracurium | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 73 | 96946-42-8 |
cismadinone | cismadinone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 54063-31-9 |
citarinostat | citarinostat | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1316215-12-9 |
citatuzumab bogatox | citatuzumab bogatox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 945228-49-9 |
cixutumumab | cixutumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 100 | 947687-12-9 |
cizolirtine | cizolirtine | 2933.19 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 142155-43-9 |
clamikalant | clamikalant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 81 | 158751-64-5 |
clascoterone | clascotérone | 2937.29 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 19608-29-8 |
clazakizumab | clazakizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1236278-28-6 |
clazosentan | clazosentan | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 90 | 180384-56-9 |
clenoliximab | clénoliximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 77 | 182912-58-9 |
clervonafusp alfa | clervonafusp alfa | 3507.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2145123-44-8 |
clevidipine | clévidipine | 2933.39 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 167221-71-8 |
clevudine | clévudine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 78 | 163252-36-6 |
cligosiban | cligosiban | 2933.39 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 900510-03-4 |
cliropamine | cliropamine | 2922.50 | 38.100 Ann. Q (No. 217) | HSC/11 | 1993 | 59 | 109525-44-2 |
clivatuzumab tetraxetan | clivatuzumab tétraxétan | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 943976-23-6 |
clobazam | clobazam | 2933.72 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 25 | 22316-47-8 |
clofarabine | clofarabine | 2934.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 123318-82-1 |
clofenoxyde | clofénoxyde | 2914.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 14 | 3030-53-3 |
clomifenoxide | clomifènoxide | 2929.90 | 40.260 Ann. L/2 (No. 12) | HSC/17 | 1996 | 54 | 97642-74-5 |
clonazepam | clonazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 22 | 1622-61-3 |
clonitazene | clonitazène | 2933.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 11 | 3861-76-5 |
cloprednol | cloprednol | 2937.22 | 42.100 Ann. O (I) | HSC/21 | 1998 | 31 | 5251-34-3 |
cloranolol | cloranolol | 2922.19 | 40.260 Ann. L/2 (No. 53) | HSC/17 | 1996 | 41 | 39563-28-5 |
clotiazepam | clotiazépam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 30 | 33671-46-4 |
cloxazolam | cloxazolam | 2934.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 29 | 24166-13-0 |
cloxestradiol | cloxestradiol | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 12 | 54063-33-1 |
cobicistat | cobicistat | 2934.10 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1004316-88-4 |
cobimetinib | cobimétinib | 2933.39 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 934660-93-2 |
cobiprostone | cobiprostone | 2937.50 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 333963-42-1 |
cobitolimod | cobitolimod | 2934.99 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1226822-98-5 |
coblopasvir | coblopasvir | 2934.99 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1312608-46-0 |
cobolimab | cobolimab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2022215-65-0 |
cobomarsen | cobomarsen | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1848257-52-2 |
codactide | codactide | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 24 | 22572-04-9 |
codoxime | codoxime | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 15 | 7125-76-0 |
codrituzumab | codrituzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1365267-33-9 |
cofetuzumab | cofétuzumab | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1869928-62-0 |
cofetuzumab pelidotin | cofétuzumab pélidotine | 3002.13 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1869937-48-3 |
coleneuramide | coléneuramide | 2932.99 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 204200-47-5 |
colesevelam | colésévélam | 3911.90 | 42.100 Ann. O (VI) | HSC/21 | 1998 | 77 | 182815-43-6 |
colestilan | colestilan | 3911.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 74 | 95522-45-5 |
colimecycline | colimécycline | 2941.30 | 40.260 Ann. L/2 (No. 5) | HSC/17 | 1996 | 33 | 58298-92-3 |
coltuximab ravtansine | coltuximab ravtansine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1269764-99-9 |
coluracetam | coluracétam | 2934.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 135463-81-9 |
conatumumab | conatumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 896731-82-1 |
conbercept | conbercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1227158-72-6 |
concizumab | concizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1312299-39-0 |
condoliase | condoliase | 3507.90 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 9024-13-9 |
conendostatin | conendostatine | 2934.99 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2202745-12-6 |
conestat alfa | conestat alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 80295-38-1 |
conivaptan | conivaptan | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 82 | 210101-16-9 |
conteltinib | conteltinib | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1384860-29-0 |
contezolid | contézolid | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1112968-42-9 |
contusugene ladenovec | contusugène ladénovec | 3002.90 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 600735-73-7 |
copanlisib | copanlisib | 2934.99 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 1032568-63-0 |
coprelotamab | coprélotamab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2348469-84-9 |
corifollitropin alfa | corifollitropine alfa | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 80 | 195962-23-3 |
cortodoxone | cortodoxone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 15 | 152-58-9 |
cosdosiran | cosdosiran | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1834560-88-1 |
cosfroviximab | cosfroviximab | 3002.13 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1792982-57-0 |
cosibelimab | cosibélimab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2216751-26-5 |
cositecan | cositécan | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 100 | 203923-89-1 |
cotadutide | cotadutide | 2937.19 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1686108-82-6 |
cotoretigene toliparvovec | cotoretigène toliparvovec | 3002.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2246424-95-1 |
cotosudil | cotosudil | 2935.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1258833-31-6 |
crenezumab | crénezumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1095207-05-8 |
crenigacestat | crénigacestat | 2933.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1421438-81-4 |
crenolanib | crénolanib | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 670220-88-9 |
cridanimod | cridanimod | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 83 | 38609-97-1 |
crilvastatin | crilvastatine | 2933.79 | 38.100 Ann. Q (No. 221) | HSC/11 | 1993 | 63 | 120551-59-9 |
crinecerfont | crinécerfont | 2934.10 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 752253-39-7 |
crisaborole | crisaborole | 2934.99 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 906673-24-3 |
crisantaspase | crisantaspase | 3507.90 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 1349719-22-7 |
crisdesalazine | crisdésalazine | 2922.50 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 927685-43-6 |
crisnatol | crisnatol | 2922.19 | 38.100 Ann. Q (No. 222) | HSC/11 | 1993 | 58 | 96389-68-3 |
crizanlizumab | crizanlizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1690318-25-2 |
crizotinib | crizotinib | 2933.39 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 877399-52-5 |
crobenetine | crobénétine | 2933.39 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 221019-25-6 |
crolibulin | crolibuline | 2932.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 1000852-17-4 |
cromakalim | cromakalim | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 58 | 94470-67-4 |
cromoglicate lisetil | cromoglicate lisétil | 2932.99 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 72 | 110816-79-0 |
crotedumab | crotédumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1452387-69-7 |
crotoniazide | crotoniazide | 2933.39 | 38.100 Ann. Q (No. 224) | HSC/11 | 1993 | 11 | 7007-96-7 |
crovalimab | crovalimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1917321-26-6 |
cudarolimab | cudarolimab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2244739-29-3 |
cupabimod | cupabimod | 2934.99 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 297774-48-2 |
cusatuzumab | cusatuzumab | 3002.13 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1864871-20-4 |
custirsen | custirsen | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 903916-27-8 |
cutamesine | cutamésine | 2933.59 | NC1500B1b Ann. K/6 | HSC/44 | 2009 | 100 | 165377-43-5 |
cyclobarbital | cyclobarbital | 2933.53 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 1 | 52-31-3 |
cyclopentolate | cyclopentolate | 2922.19 | 40.260 Ann. L/2 (No. 54) | HSC/17 | 1996 | 39 | 512-15-2 |
cystine | cystine | 2930.90 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 56-89-3 |
cytisinicline | cytisinicline | 2933.79 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 485-35-8 |
dabelotine | dabélotine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 118976-38-8 |
dabigatran | dabigatran | 2933.39 | NC0430B2 Ann. Q/1 (II) | HSC/27 | 2001 | 83 | 211914-51-1 |
dabigatran etexilate | dabigatran étexilate | 2933.39 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 211915-06-9 |
dabrafenib | dabrafénib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 105 | 1195765-45-7 |
dacetuzumab | dacétuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 98 | 880486-59-9 |
daclatasvir | daclatasvir | 2933.29 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 107 | 1099119-64-5 |
daclizumab | daclizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 78 | 152923-56-3 |
daclizumab beta | daclizumab bêta | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 152923-56-3 |
dacomitinib | dacomitinib | 2933.59 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 1110813-31-4 |
dactolisib | dactolisib | 2933.49 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 915019-65-7 |
dafsolimab | dafsolimab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2367001-71-4 |
dafsolimab setaritox | dafsolimab sétaritox | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2361013-28-5 |
daglutril | daglutril | 2933.79 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 182821-27-8 |
dagrocorat | dagrocorat | 2933.39 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1044535-52-5 |
dalantercept | dalantercept | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 105 | 1186210-24-1 |
dalatazide | dalatazide | 3002.49 | NC2803Bc Ann. T/9 | HSC/67 | 2021 | 111 | 1081110-69-1 |
dalbavancin | dalbavancine | 2941.90 | NC0590B2 Ann. L/15 | HSC/29 | 2002 | 85 | 171500-79-1 |
dalbraminol | dalbraminol | 2933.19 | 38.100 Ann. Q (No. 225) | HSC/11 | 1993 | 58 | 81528-80-5 |
dalcetrapib | dalcétrapib | 2930.90 | NC1310B1b Ann. N/10 | HSC/41 | 2008 | 96 | 211513-37-0 |
dalcinonacog alfa | dalcinonacog alfa | 3002.12 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2055206-13-6 |
dalcotidine | dalcotidine | 2933.39 | 42.100 Ann. O (V) | HSC/21 | 1998 | 76 | 120958-90-9 |
dalosirvat | dalosirvat | 2932.99 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1360540-81-3 |
dalotuzumab | dalotuzumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 102 | 1005389-60-5 |
dalpiciclib | dalpiciclib | 2933.79 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1637781-04-4 |
dalteparin sodium | daltéparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 64 | 9041-08-1 |
damoctocog alfa pegol | damoctocog alfa pégol | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1363853-26-2 |
danaparoid sodium | danaparoïde sodique | 3913.90 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 83513-48-8 |
danavorexton | danavorexton | 2935.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2114324-48-8 |
danegaptide | danégaptide | 2933.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 101 | 943134-39-2 |
danicamtiv | danicamtiv | 2934.99 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1970972-74-7 |
danicopan | danicopan | 2933.59 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1903768-17-1 |
daniplestim | daniplestim | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 76 | 161753-30-6 |
daniquidone | daniquidone | 2933.79 | 38.100 Ann. Q (No. 226) | HSC/11 | 1993 | 62 | 67199-66-0 |
danirixin | danirixine | 2933.39 | NC1874B1b Ann. O/2 | HSC/51 | 2013 | 107 | 954126-98-8 |
danoprevir | danoprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 102 | 916881-67-9 |
danusertib | danusertib | 2933.59 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 827318-97-8 |
danvatirsen | danvatirsen | 2934.99 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1402100-56-4 |
dapabutan | dapabutan | 2922.49 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 6582-31-6 |
dapaconazole | dapaconazole | 2933.29 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1269726-67-1 |
dapagliflozin | dapagliflozine | 2932.99 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 461432-26-8 |
dapansutrile | dapansutrile | 2930.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 54863-37-5 |
dapatifagene navolactibac | dapatifagène navolactibac | 3002.90 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | |
dapiclermin | dapiclermine | 2933.29 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 444069-80-1 |
dapiglutide | dapiglutide | 2937.19 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2296814-85-0 |
dapirolizumab pegol | dapirolizumab pégol | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 110 | 1416147-64-2 |
dapitant | dapitant | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 153438-49-4 |
dapivirine | dapivirine | 2933.59 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 244767-67-7 |
daplusiran | daplusiran | 2934.99 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2202783-38-6 |
daporinad | daporinad | 2933.39 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 201034-75-5 |
daprodustat | daprodustat | 2933.54 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 960539-70-2 |
darapladib | darapladib | 2933.59 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 356057-34-6 |
daratumumab | daratumumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 101 | 945721-28-8 |
darbepoetin alfa | darbépoétine alfa | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 85 | 209810-58-2 |
darbufelone | darbufélone | 2934.10 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 139226-28-1 |
darexaban | darexaban | 2933.99 | NC1604B1b Ann. N/5 | HSC/46 | 2010 | 104 | 365462-23-3 |
darglitazone | darglitazone | 2934.10 | 39.600 Ann. D/1, par. 15 | HSC/16 | 1995 | 69 | 141200-24-0 |
daridorexant | daridorexant | 2933.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 120 | 1505484-82-1 |
darifenacin | darifénacine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 70 | 133099-04-4 |
darigabat | darigabat | 2933.99 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1614245-70-3 |
darinaparsin | darinaparsine | 2930.90 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 69819-86-9 |
darolutamide | darolutamide | 2933.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1297538-32-9 |
darotropium bromide | bromure de darotropium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 850607-58-8 |
darovasertib | darovasertib | 2933.39 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1874276-76-2 |
darsidormine | darsidomine | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 74 | 137500-42-6 |
darunavir | darunavir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 88 | 206361-99-1 |
darusentan | darusentan | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 171714-84-4 |
darvadstrocel | darvadstrocel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 117 | |
dasabuvir | dasabuvir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 109 | 1132935-63-7 |
dasantafil | dasantafil | 2933.59 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 569351-91-3 |
dasatinib | dasatinib | 2934.10 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 302962-49-8 |
dasiglucagon | dasiglucagon | 2937.19 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1544300-84-6 |
dasolampanel | dasolampanel | 2933.49 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 503294-13-1 |
dasotraline | dasotraline | 2921.49 | NC2116B1b Ann. R/4 | HSC/55 | 2015 | 110 | 675126-05-3 |
datelliptium chloride | chlorure de datelliptium | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 57 | 105118-14-7 |
datopotamab | datopotamab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2267989-53-5 |
datopotamab deruxtecan | datopotamab déruxtécan | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2238831-60-0 |
davalintide | davalintide | 2937.19 | NC1649B3b Ann. R/12 | HSC/47 | 2011 | 101 | 863919-85-1 |
davamotecan pegadexamer | davamotécan pégadexamère | 2939.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1883668-61-8 |
davasaicin | davasaïcine | 2924.29 | NC1178B1c Ann. O/2 | HSC/39 | 2007 | 92 | 147497-64-1 |
davunetide | davunétide | 2933.99 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 211439-12-2 |
daxalipram | daxalipram | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 189940-24-7 |
daxdilimab | daxdilimab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2245966-28-1 |
dazcapistat | dazcapistat | 2934.99 | NC2803Bc Ann. T/11 | HSC/67 | 2021 | 124 COVID-19 | 2221010-42-8 |
dazodalibep | dazodalibep | 2934.99 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2245953-10-8 |
decernotinib | décernotinib | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 110 | 944842-54-0 |
decitropine | décitropine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 18 | 1242-69-9 |
declenperone | déclenpérone | 2933.39 | 38.100 Ann. Q (No. 228) | HSC/11 | 1993 | 42 | 63388-37-4 |
declopramide | déclopramide | 2924.29 | 42.750 Ann. O | HSC/22 | 1998 | 78 | 891-60-1 |
decoglurant | décoglurant | 2933.59 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 911115-16-7 |
decominol | décominol | 2922.19 | 40.260 Ann. L/2 (No. 55) | HSC/17 | 1996 | 45 | 60812-35-3 |
dectrekumab | dectrékumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1528523-94-5 |
defactinib | défactinib | 2935.90 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 111 | 1073154-85-4 |
deferasirox | déférasirox | 2933.99 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 201530-41-8 |
deferitazole | déféritazole | 2934.10 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 945635-15-4 |
deferitrin | déféritrine | 2934.10 | NC1004B1b Ann. L/11 | HSC/36 | 2005 | 92 | 239101-33-8 |
deflazacort | déflazacort | 2937.29 | 38.100 Ann. Q (No. 229) | HSC/11 | 1993 | 39 | 14484-47-0 |
defoslimod | défoslimod | 2932.99 | NC0430B2 Ann. Q/1 (III) | HSC/27 | 2001 | 79 | 171092-39-0 |
degarelix | dégarélix | 2937.19 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 214766-78-6 |
delafloxacin | délafloxacine | 2933.49 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 189279-58-1 |
delamanid | délamanid | 2934.99 | NC1760B1b Ann. N/7 | HSC/49 | 2012 | 104 | 681492-22-8 |
delanzomib | délanzomib | 2933.39 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 847499-27-8 |
delavirdine | délavirdine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 71 | 136817-59-9 |
delcasertib | delcasertib | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 949100-39-4 |
deldeprevir | deldéprévir | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 110 | 1229626-28-1 |
deleobuvir | déléobuvir | 2933.59 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 863884-77-9 |
delequamine | déléquamine | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 73 | 119905-05-4 |
delgocitinib | delgocitinib | 2933.59 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1263774-59-9 |
deligoparin sodium | déligoparine sodique | 3001.90 | NC1553B1b Ann. O/5 | HSC/45 | 2010 | 89 | 9041-08-1 |
delimotecan | délimotécan | 2939.79 | NC2237B1b Ann. T/12 | HSC/57 | 2016 | 97 | 187852-63-7 |
delmitide | delmitide | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 92 | 287096-87-1 |
delolimogene mupadenorepvec | délolimogène mupadénorépvec | 3002.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 2061938-98-3 |
delorazepam | délorazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 40 | 2894-67-9 |
deloxolone | déloxolone | 2918.19 | 38.100 Ann. Q (No. 230) | HSC/11 | 1993 | 51 | 68635-50-7 |
delparantag | delparantag | 2924.29 | NC2004B1b Ann. O/4 | HSC/53 | 2014 | 108 | 872454-31-4 |
delpazolid | delpazolid | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1219707-39-7 |
deltibant | deltibant | 2933.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 75 | 140661-97-8 |
delucemine | délucémine | 2921.49 | NC0730B2 Ann. M/7 | HSC/31 | 2003 | 87 | 186495-49-8 |
dematirsen | dématirsen | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1802465-55-9 |
demcizumab | demcizumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1243262-17-0 |
demegestone | démégestone | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 24 | 10116-22-0 |
demiditraz | demiditraz | 2933.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 944263-65-4 |
demplatin pegraglumer | demplatine pégraglumère | 2843.90 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1009838-50-9 |
demupitamab | démupitamab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2249926-74-5 |
denagliptin | dénagliptine | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 483369-58-0 |
denaverine | dénavérine | 2922.19 | 40.260 Ann. L/2 (No. 56) | HSC/17 | 1996 | 25 | 3579-62-2 |
denbufylline | denbufylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 55 | 57076-71-8 |
denenicokin | dénénicokine | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 99 | 716840-32-3 |
denibulin | dénibuline | 2933.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 284019-34-7 |
denileukin diffitox | dénileukine diftitox | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 78 | 173146-27-5 |
denintuzumab mafodotine | dénintuzumab mafodotine | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1399672-02-6 |
denosumab | dénosumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 94 | 615258-40-7 |
denotivir | dénotivir | 2934.10 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 51287-57-1 |
denufosol | dénufosol | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 211448-85-0 |
deoxycholic acid | acide désoxycholique | 2918.19 | NC1874B1B Ann. O/1 | HSC/51 | 2013 | 106 | 83-44-3 |
depatuxizumab | dépatuxizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1471999-69-5 |
depatuxizumab mafodotin | dépatuxizumab mafodotine | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1585973-65-4 |
depelestat | dépélestat | 2934.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 506433-25-6 |
depemokimab | dépémokimab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2243274-14-6 |
depreotide | dépréotide | 2933.79 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 161982-62-3 |
deptropine | deptropine | 2939.79 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 12 | 604-51-3 |
deracoxib | déracoxib | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 80 | 169590-41-4 |
derazantinib | dérazantinib | 2933.59 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1234356-69-4 |
derenofylline | dérénofylline | 2933.59 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 251945-92-3 |
derpanicate | derpanicate | 2933.39 | 38.100 Ann. Q (No. 233) | HSC/11 | 1993 | 58 | 99518-29-3 |
derquantel | derquantel | 2934.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 187865-22-1 |
dersalazine | dersalazine | 2933.39 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 188913-58-8 |
dersimelagon | dersimélagon | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1835256-48-8 |
desaspidin | désaspidine | 2914.50 | 42.100 Ann. O (I) | HSC/21 | 1998 | 15 | 114-43-2 |
desciclovir | desciclovir | 2933.59 | 38.100 Ann. Q (No. 234) | HSC/11 | 1993 | 55 | 84408-37-7 |
descinolone | descinolone | 2937.22 | 38.100 Ann. Q (No. 235) | HSC/11 | 1993 | 17 | 595-52-8 |
desfesoterodine | desfésotérodine | 2922.50 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 207679-81-0 |
desidustat | désidustat | 2933.79 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 1616690-16-4 |
desirudin | désirudine | 3001.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 120993-53-5 |
deslanoside | deslanoside | 2938.90 | 38.100 Ann. Q (No. 236) | HSC/11 | 1993 | 14 | 17598-65-1 |
desloratadine | desloratadine | 2933.39 | NC0090B2 Ann. M/5 | HSC/23 | 1999 | 80 | 100643-71-8 |
desmeninol | desméninol | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 583-91-5 |
desmetramadol | desmétramadol | 2922.50 | NC2501B1b Ann. M/6 | HSC/61 | 2018 | 117 | 80456-81-1 |
desmopressin | desmopressine | 2937.19 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 33 | 16679-58-6 |
desmoteplase | desmoteplase | 3507.90 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 145137-38-8 |
desomorphine | désomorphine | 2939.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 427-00-9 |
desoximetasone | désoximétasone | 2937.22 | 38.100 Ann. Q (No. 238) | HSC/11 | 1993 | 20 | 382-67-2 |
detanosal | détanosal | 2922.19 | 40.260 Ann. L/2 (No. 57) | HSC/17 | 1996 | 23 | 23573-66-2 |
detiviciclovir | détiviciclovir | 2933.59 | NC0730B2 Ann. M/6 | HSC/31 | 2003 | 86 | 220984-26-9 |
detumomab | détumomab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 70 | 145832-33-3 |
deucravacitinib | deucravacitinib | 2845.90 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 1609392-27-9 |
deudextromethorphan | deudextromethorphane | 2845.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1079043-55-2 |
deutetrabenazine | deutétrabénazine | 2845.90 | NC2237B1b Ann. S/8 | HSC/57 | 2016 | 112 | 1392826-25-3 |
deutivacaftor | deutivacaftor | 2845.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1413431-07-8 |
deutolperisone | deutolpérisone | 2845.90 | NC1059B2b Ann. O/4 | HSC/37 | 2006 | 92 | 474641-19-5 |
devafidugene civaparvovec | devafidugène civaparvovec | 3002.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2143580-11-2 |
devimistat | dévimistat | 2930.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 95809-78-2 |
dexamethasone cipecilate | cipécilate de dexaméthasone | 2937.22 | NC1178B1c Ann. O/3 | HSC/39 | 2007 | 94 | 132245-57-9 |
dexamfetamine | dexamfétamine | 2921.46 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 55 | 51-64-9 |
dexbudesonide | dexbudésonide | 2932.99 | NC0250B2 Ann. P/1 (I) | HSC/25 | 2000 | 80 | 51372-29-3 |
dexecadotril | dexécadotril | 2930.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 112573-72-5 |
dexefaroxan | dexéfaroxan | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 76 | 143249-88-1 |
dexelvucitabine | dexelvucitabine | 2934.99 | NC1178B1c Ann. O/5 | HSC/39 | 2007 | 95 | 134379-77-4 |
dexisometheptene | dexisométhéptène | 2921.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1620401-56-0 |
dexketoprofen | dexkétoprofène | 2918.30 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 22161-81-5 |
dexlansoprazole | dexlansoprazole | 2933.39 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 138530-94-6 |
dexmecamylamine | dexmécamylamine | 2921.30 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 107538-05-6 |
dexmethylphenidate | dexméthylphénidate | 2933.39 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 40431-64-9 |
dexnebivolol | dexnébivolol | 2932.99 | NC1443B1b Ann. P/5 | HSC/43 | 2009 | 98 | 118457-15-1 |
dexpemedolac | dexpémédolac | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 114030-44-3 |
dexpramipexole | dexpramipexole | 2934.20 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 104632-28-2 |
dexpropranolol | dexpropranolol | 2922.19 | 40.260 Ann. L/2 (No. 58) | HSC/17 | 1996 | 21 | 5051-22-9 |
dexsotalol | dexsotalol | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 74 | 30236-32-9 |
dextiopronin | dextiopronine | 2930.90 | NC0090B2 Ann. M/1 (II) | HSC/23 | 1999 | 79 | 29335-92-0 |
dextofisopam | dextofisopam | 2933.99 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 82059-50-5 |
dextromethorphan | dextrométhorphane | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 125-71-3 |
dextromoramide | dextromoramide | 2934.91 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 6 | 357-56-2 |
dextropropoxyphene | dextropropoxyphène | 2922.14 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 469-62-5 |
dextrorphan | dextrorphane | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 1 | 125-73-5 |
dezaguanine | dézaguanine | 2933.79 | 38.100 Ann. Q (No. 241) | HSC/11 | 1993 | 51 | 41729-52-6 |
dezamizumab | dézamizumab | 3002.13 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1662664-56-3 |
dezapelisib | dézapélisib | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1262440-25-4 |
diampromide | diampromide | 2924.29 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 10 | 552-25-0 |
dianexin | dianexine | 3002.12 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 109 | 1352413-49-0 |
dianhydrogalactitol | dianhydrogalactitol | 2910.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 23261-20-3 |
dianicline | dianicline | 2934.99 | NC1059B2b Ann. O/5 | HSC/37 | 2006 | 93 | 292634-27-6 |
diaplasinin | diaplasinine | 2933.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 481631-45-2 |
diazepam | diazépam | 2933.91 | E.N. Chap. 29 - List I-II (Psychotropic) | HSC/25 | 2000 | 12 | 439-14-5 |
dibotermin alfa | dibotermine alfa | 2933.29 | NC0938B2b Ann. O/2 | HSC/35 | 2005 | 89 | 246539-15-1 |
dibunate | dibunate | 2904.10 | 38.100 Ann. Q (No. 69) | HSC/11 | 1993 | 48 | |
dichlorisone | dichlorisone | 2937.22 | 38.100 Ann. Q (No. 242) | HSC/11 | 1993 | 10 | 7008-26-6 |
diciferron | diciferron | 2931.90 | NC2373B1b Ann. O/12 | HSC/59 | 2017 | 44 | 65606-61-3 |
dicirenone | dicirénone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 50 | 41020-79-5 |
diclofenac etalhyaluronate | étalhyaluronate de diclofénac | 3913.90 | NC2116B1b Ann. R/5 | HSC/55 | 2015 | 111 | 1608089-20-8 |
dicobalt edetate | édétate dicobaltique | 2922.49 | 38.100 Ann. Q (No. 245) | HSC/11 | 1993 | 45 | 36499-65-7 |
dienestrol | diènestrol | 2907.29 | 38.100 Ann. Q (No. 246) | HSC/11 | 1993 | 1 | 84-17-3 |
dienogest | diénogest | 2937.23 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 49 | 65928-58-7 |
diethylstilbestrol | diéthylstilbestrol | 2907.29 | 38.100 Ann. Q (No. 248) | HSC/11 | 1993 | 4 | 56-53-1 |
diethylthiambutene | diéthylthiambutène | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 3 | 86-14-6 |
dietifen | diétifène | 2922.19 | 40.260 Ann. L/2 (No. 59) | HSC/17 | 1996 | 22 | 3686-78-0 |
difamilast | difamilast | 2934.99 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 937782-05-3 |
difelikefalin | difélikéfaline | 2933.39 | NC2237B1b Ann. S/9 | HSC/57 | 2016 | 113 | 1024828-77-0 |
difemerine | difémérine | 2922.19 | 40.260 Ann. L/2 (No. 60) | HSC/17 | 1996 | 17 | 80387-96-8 |
difenoximide | difénoximide | 2933.39 | 38.100 Ann. Q (No. 249) | HSC/11 | 1993 | 32 | 47806-92-8 |
difenoxin | difénoxine | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 25 | 28782-42-5 |
difeterol | difétérol | 2922.19 | 40.260 Ann. L/2 (No. 61) | HSC/17 | 1996 | 36 | 14587-50-9 |
diflomotecan | diflomotécan | 2934.99 | NC2237B1b Ann. S/11 | HSC/57 | 2016 | 84 | 220997-97-7 |
difluprednate | difluprednate | 2937.22 | 38.100 Ann. Q (No. 250) | HSC/11 | 1993 | 21 | 23674-86-4 |
dihydrocodeine | dihydrocodéine | 2939.11 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 8 | 125-28-0 |
dilanubicel | dilanubicel | 3002.51 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 119 | |
dilmapimod | dilmapimod | 2933.79 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 444606-18-2 |
dilopetine | dilopétine | 2934.99 | NC1123B1b Ann. N/1 | HSC/38 | 2006 | 94 | 247046-52-2 |
dilpacimab | dilpacimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1791420-09-1 |
diltiazem | diltiazem | 2934.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 30 | 42399-41-7 |
dimabefylline | dimabéfylline | 2939.59 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 19 | 1703-48-6 |
dimadectin | dimadectine | 2941.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 73 | 156131-91-8 |
dimelazine | dimélazine | 2934.30 | 38.100 Ann. Q (No. 253) | HSC/11 | 1993 | 14 | 15302-12-2 |
dimenoxadol | diménoxadol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 7 | 509-78-4 |
dimepheptanol | dimépheptanol | 2922.19 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 545-90-4 |
dimesone | dimésone | 2937.22 | 38.100 Ann. Q (No. 254) | HSC/11 | 1993 | 23 | 25092-07-3 |
dimethylthiambutene | diméthylthiambutène | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 3 | 524-84-5 |
dinaciclib | dinaciclib | 2933.59 | NC1649B3b Ann. R/13 | HSC/47 | 2011 | 102 | 779353-01-4 |
dinalbuphine sebacate | sébacate de dinalbuphine | 2939.19 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 116 | 311768-81-7 |
dinutuximab | dinutuximab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 109 | 1363687-32-4 |
dinutuximab beta | dinutuximab bêta | 3002.13 | NC2237B1b Ann. T/11 | HSC/57 | 2016 | 113 | 1613303-02-8 |
dioxaphetyl butyrate | butyrate de dioxaphétyl | 2934.99 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 467-86-7 |
diphenoxylate | diphénoxylate | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 10 | 915-30-0 |
dipipanone | dipipanone | 2933.33 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 5 | 467-83-4 |
diprafenone | diprafénone | 2922.19 | 40.260 Ann. L/2 (No. 63) | HSC/17 | 1996 | 48 | 81447-80-5 |
dipraglurant | dipraglurant | 2933.39 | NC1604B1b Ann. N/6 | HSC/46 | 2010 | 102 | 872363-17-2 |
diprogulic acid | acide diprogulique | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 35 | 18467-77-1 |
diridavumab | diridavumab | 3002.13 | NC2237B1b Ann. T/13 | HSC/57 | 2016 | 111 | 1393659-46-5 |
dirithromycin | dirithromycine | 2941.50 | 38.100 Ann. Q (No. 256) | HSC/11 | 1993 | 53 | 62013-04-1 |
dirloctocogene samoparvovec | dirloctocogène samoparvovec | 3002.90 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2163074-23-3 |
dirlotapide | dirlotapide | 2933.99 | NC0938B2b Ann. O/3 (II) | HSC/35 | 2005 | 91 | 481658-94-0 |
dirocaftor | dirocaftor | 2933.49 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2137932-23-9 |
diroleuton | diroleuton | 2916.19 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 1783-84-2 |
diroximel fumarate | fumarate de diroximel | 2925.19 | NC2373B1b Ann. O/7 | HSC/59 | 2017 | 115 | 1577222-14-0 |
dirucotide | dirucotide | 2933.29 | NC1553B1b Ann. O/7 | HSC/45 | 2010 | 100 | 152074-97-0 |
disitamab | disitamab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2185868-98-6 |
disitamab vedotin | disitamab védotine | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 2136633-23-1 |
disitertide | disitertide | 2933.99 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 272105-42-7 |
disogluside | disogluside | 2938.90 | 38.100 Ann. Q (No. 257) | HSC/11 | 1993 | 47 | 14144-06-0 |
disomotide | disomotide | 3002.41 | NC2803Bc Ann. T/4 | HSC/67 | 2021 | 94 | 181477-43-0 |
disufenton sodium | disufenton sodique | 2929.90 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 168021-79-2 |
disulergine | disulergine | 2939.69 | 42.100 Ann. O (I) | HSC/21 | 1998 | 45 | 59032-40-5 |
disulfiram | disulfirame | 2930.30 | 38.100 Ann. Q (No. 258) | HSC/11 | 1993 | 1 | 97-77-8 |
disuprazole | disuprazole | 2933.39 | 38.100 Ann. Q (No. 259) | HSC/11 | 1993 | 56 | 99499-40-8 |
ditekiren | ditékirène | 2933.39 | 38.100 Ann. Q (No. 260) | HSC/11 | 1993 | 84 | 103336-05-6 |
ditercalinium chloride | chlorure de ditercalinium | 2933.39 | 38.100 Ann. Q (No. 261) | HSC/11 | 1993 | 49 | 74517-42-3 |
dithranol | dithranol | 2914.50 | 38.100 Ann. Q (No. 262) | HSC/11 | 1993 | 4 | 480-22-8 |
divaplon | divaplone | 2933.59 | 38.100 Ann. Q (No. 263) | HSC/11 | 1993 | 61 | 90808-12-1 |
divozilimab | divozilimab | 3002.13 | NC2803Bc Ann. T/7 | HSC/67 | 2021 | 123 | 2254061-60-2 |
dizocilpine | dizocilpine | 2933.49 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 60 | 77086-21-6 |
docaravimab | docaravimab | 3002.13 | NC2803Bc Ann. T/6 | HSC/67 | 2021 | 122 | 2247196-23-0 |
docetaxel | docétaxel | 2932.99 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 71 | 114977-28-5 |
dociparstat sodium | dociparstat sodique | 3913.90 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 177021-00-0 |
dofequidar | doféquidar | 2933.59 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 129716-58-1 |
dolcanatide | dolcanatide | 2937.19 | NC2501B1b Ann. M/3 | HSC/61 | 2018 | 114 | 1092457-65-2 |
dolutegravir | dolutégravir | 2934.99 | NC1760B1b Ann. N/8 | HSC/49 | 2012 | 105 | 1051375-16-6 |
domagrozumab | domagrozumab | 3002.13 | NC2373B1b Ann. O/6 | HSC/59 | 2017 | 114 | 1629605-31-7 |
domatinostat | domatinostat | 2935.90 | NC2626B1b Ann. O/5 | HSC/63 | 2019 | 118 | 910462-43-0 |
domitroban | domitroban | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 73 | 112966-96-8 |
domoprednate | domoprednate | 2937.29 | 38.100 Ann. Q (No. 266) | HSC/11 | 1993 | 47 | 66877-67-6 |
domperidone | dompéridone | 2933.39 | 38.100 Ann. Q (No. 267) | HSC/11 | 1993 | 36 | 57808-66-9 |
donanemab | donanémab | 3002.13 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1931944-80-7 |
donaperminogene seltoplasmid | donaperminogène seltoplasmide | 2934.99 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1787232-87-4 |
donepezil | donépézil | 2933.39 | 42.100 Ann. O (IV) | HSC/21 | 1998 | 75 | 120014-06-4 |
donitriptan | donitriptan | 2933.59 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 170912-52-4 |
doqualast | doqualast | 2933.59 | 38.100 Ann. Q (No. 268) | HSC/11 | 1993 | 48 | 64019-03-0 |
doramapimod | doramapimod | 2934.99 | NC0845B2 Ann. M/2 | HSC/33 | 2004 | 88 | 285983-48-4 |
doramectin | doramectine | 2941.90 | 38.100 Ann. Q (No. 269) | HSC/11 | 1993 | 65 | 117704-25-3 |
doranidazole | doranidazole | 2933.29 | NC0938B2b Ann. O/3 (I) | HSC/35 | 2005 | 90 | 149838-23-3 |
dorastine | dorastine | 2933.39 | 38.100 Ann. Q (No. 270) | HSC/11 | 1993 | 23 | 21228-13-7 |
doravirine | doravirine | 2933.79 | NC2004B1b Ann. O/5 | HSC/53 | 2014 | 109 | 1338225-97-0 |
doripenem | doripénem | 2941.90 | NC0590B2 Ann. L/10 | HSC/29 | 2002 | 83 | 148016-81-3 |
dornase alfa | dornase alfa | 3507.90 | 40.600 Ann. D, par. 6 | HSC/18 | 1996 | 70 | 143831-71-4 |
dorzagliatin | dorzagliatine | 2933.79 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1191995-00-2 |
dosergoside | dosergoside | 2939.69 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 54 | 87178-42-5 |
dostarlimab | dostarlimab | 3002.13 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 2022215-59-2 |
dotinurad | dotinurad | 2934.20 | NC2501B1b Ann. M/5 | HSC/61 | 2018 | 116 | 1285572-51-1 |
dovanvetmab | dovanvetmab | 3002.13 | NC2803Bc Ann. T/3 | HSC/67 | 2021 | 121 | 2171034-71-0 |
dovitinib | dovitinib | 2933.79 | NC1310B1b Ann. N/4 | HSC/41 | 2008 | 97 | 405169-16-6 |
doxercalciferol | doxercalciférol | 2936.29 | NC0430B2 Ann. Q/1 (I) | HSC/27 | 2001 | 82 | 54573-75-0 |
draquinolol | draquinolol | 2933.79 | 38.100 Ann. Q (No. 272) | HSC/11 | 1993 | 54 | 67793-71-9 |
drinabant | drinabant | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 99 | 358970-97-5 |
drisapersen | drisapersen | 2934.99 | NC1874B1b Ann. O/1 | HSC/51 | 2013 | 106 | 1251830-50-8 |
droloxifene | droloxifène | 2922.19 | 40.260 Ann. L/2 (No. 64) | HSC/17 | 1996 | 53 | 82413-20-5 |
dronedarone | dronédarone | 2935.90 | NC2116B1b Ann. S/1 | HSC/55 | 2015 | 75 | 141626-36-0 |
drospirenone | drospirénone | 2937.29 | NC2004B1b Ann. O/6 | HSC/53 | 2014 | 63 | 67392-87-4 |
drotebanol | drotébanol | 2933.49 | E.N. Chap. 29 - List I-I (Narcotic drugs) | HSC/25 | 2000 | 24 | 3176-03-2 |
drotrecogin alfa (activated) | drotrécogine alfa (activé) | 3002.12 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 86 | 98530-76-8 |
droxinavir | droxinavir | 2924.21 | 42.100 Ann. O (III) | HSC/21 | 1998 | 74 | 159910-86-8 |
drozitumab | drozitumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 103 | 912628-39-8 |
dubermatinib | dubermatinib | 2935.90 | NC2803Bc Ann. T/2 | HSC/67 | 2021 | 120 | 1341200-45-0 |
dulaglutide | dulaglutide | 2937.19 | NC1649B3b Ann. R/14 | HSC/47 | 2011 | 103 | 923950-08-7 |
dulanermin | dulanermine | 2933.29 | NC1443B1b Ann. P/6 | HSC/43 | 2009 | 99 | 867153-61-5 |
duligotumab | duligotumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 107 | 1314238-96-4 |
dupilumab | dupilumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1190264-60-8 |
durlobactam | durlobactam | 2933.39 | NC2626B1b Ann. O/6 | HSC/63 | 2019 | 119 | 1467829-71-5 |
durvalumab | durvalumab | 3002.13 | NC2237B1b Ann. T/10 | HSC/57 | 2016 | 112 | 1428935-60-7 |
dusigitumab | dusigitumab | 3002.13 | NC2116B1b Ann. S/2 | HSC/55 | 2015 | 108 | 1204390-13-5 |
dusquetide | dusquétide | 2933.99 | NC2237B1b Ann. S/9 | HSC/57 |